<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">ACS Omega</journal-id>
    <journal-id journal-id-type="iso-abbrev">ACS Omega</journal-id>
    <journal-id journal-id-type="publisher-id">ao</journal-id>
    <journal-id journal-id-type="coden">acsodf</journal-id>
    <journal-title-group>
      <journal-title>ACS Omega</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2470-1343</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9670693</article-id>
    <article-id pub-id-type="doi">10.1021/acsomega.2c04465</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>iAMAP-SCM: A Novel
Computational Tool for Large-Scale
Identification of Antimalarial Peptides Using Estimated Propensity
Scores of Dipeptides</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <name>
          <surname>Charoenkwan</surname>
          <given-names>Phasit</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <name>
          <surname>Schaduangrat</surname>
          <given-names>Nalini</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <name>
          <surname>Lio</surname>
          <given-names>Pietro</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <name>
          <surname>Moni</surname>
          <given-names>Mohammad Ali</given-names>
        </name>
        <xref rid="aff4" ref-type="aff">∥</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath5">
        <name>
          <surname>Chumnanpuen</surname>
          <given-names>Pramote</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff5" ref-type="aff">⊥</xref>
        <xref rid="aff6" ref-type="aff">#</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath6">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3394-8709</contrib-id>
        <name>
          <surname>Shoombuatong</surname>
          <given-names>Watshara</given-names>
        </name>
        <xref rid="cor2" ref-type="other">*</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Modern
Management and Information Technology, College of Arts, Media and
Technology, <institution>Chiang Mai University</institution>, Chiang Mai50200, <country>Thailand</country></aff>
      <aff id="aff2"><label>‡</label>Center
of Data Mining and Biomedical Informatics, Faculty of Medical Technology, <institution>Mahidol University</institution>, Bangkok10700, <country>Thailand</country></aff>
      <aff id="aff3"><label>§</label>Department
of Computer Science and Technology, <institution>University
of Cambridge</institution>, CambridgeshireCB3 0FD, <country>U.K.</country></aff>
      <aff id="aff4"><label>∥</label>Artificial
Intelligence &amp; Digital Health, School of Health and Rehabilitation
Sciences, Faculty of Health and Behavioural Sciences, <institution>The University of Queensland</institution>, St LuciaQLD 4072, <country>Australia</country></aff>
      <aff id="aff5"><label>⊥</label>Department
of Zoology, Faculty of Science, <institution>Kasetsart
University</institution>, Bangkok10900, <country>Thailand</country></aff>
      <aff id="aff6"><label>#</label>Omics Center
for Agriculture, Bioresources, Food, and Health, <institution>Kasetsart University (OmiKU)</institution>, Bangkok10900, <country>Thailand</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>pramote.c@ku.th</email>.</corresp>
      <corresp id="cor2"><label>*</label>Email: <email>watshara.sho@mahidol.ac.th</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>02</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>15</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <volume>7</volume>
    <issue>45</issue>
    <fpage>41082</fpage>
    <lpage>41095</lpage>
    <history>
      <date date-type="received">
        <day>15</day>
        <month>07</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>20</day>
        <month>10</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2022 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2022</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_0007" id="ab-tgr1"/>
      </p>
      <p>Antimalarial peptides (AMAPs) varying in length, amino
acid composition,
charge, conformational structure, hydrophobicity, and amphipathicity
reflect their diversity in antimalarial mechanisms. Due to the worldwide
major health problem concerning antimicrobial resistance, these peptides
possess great therapeutic value owing to their low incidences of drug
resistance as compared to conventional antibiotics. Although well-known
experimental methods are able to precisely determine the antimalarial
activity of peptides, these methods are still time-consuming and costly.
Thus, machine learning (ML)-based methods that are capable of identifying
AMAPs rapidly by using only sequence information would be beneficial
for the high-throughput identification of AMAPs. In this study, we
propose the first computational model (termed iAMAP-SCM) for the large-scale
identification and characterization of peptides with antimalarial
activity by using only sequence information. Specifically, we employed
an interpretable scoring card method (SCM) to develop iAMAP-SCM and
estimate propensities of 20 amino acids and 400 dipeptides to be AMAPs
in a supervised manner. Experimental results showed that iAMAP-SCM
could achieve a maximum accuracy and Matthew’s coefficient
correlation of 0.957 and 0.834, respectively, on the independent test
dataset. In addition, SCM-derived propensities of 20 amino acids and
selected physicochemical properties were used to provide an understanding
of the functional mechanisms of AMAPs. Finally, a user-friendly online
computational platform of iAMAP-SCM is publicly available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pmlabstack.pythonanywhere.com/iAMAP-SCM">http://pmlabstack.pythonanywhere.com/iAMAP-SCM</uri>. The iAMAP-SCM predictor is anticipated to assist experimental scientists
in the high-throughput identification of potential AMAP candidates
for the treatment of malaria and other clinical applications.</p>
    </abstract>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Chiang Mai University</institution>
            <institution-id institution-id-type="doi">10.13039/501100002842</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NA</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>College of Arts, Media and Technology, Chiang Mai University</institution>
            <institution-id institution-id-type="doi">NA</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NA</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Mahidol University</institution>
            <institution-id institution-id-type="doi">10.13039/501100004156</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NA</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ao2c04465</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ao2c04465</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <label>1</label>
    <title>Introduction</title>
    <p>Malaria is a global public
health concern as it causes millions
of deaths annually. Its causative agent, <italic>Plasmodium
falciparum</italic>, poses a serious medical challenge.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Currently, the development of novel strategies
for combating this epidemic disease includes screening of novel antimalarial
drugs as a means to curb parasite transmission and thus decrease the
mortality rate.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Antimicrobial peptides
(AMPs) are composed of both naturally and synthetically derived molecules
with features such as charge, secondary structure features, molecular
weight, and hydrophobicity, to name a few. Even though they are better
known for their antimicrobial properties, many AMPs also exhibit broad-spectrum
activities toward pathogenic microbiota including the malarial parasite.
AMPs target the growth of the malarial parasite at different life
cycle stages such as the vertebrate blood stage or the mosquito stage.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> Polypeptides remain an alternative antimicrobial
agent since they have been actively tested against various pathogenic
microbes<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> and lead to novel strategies
for therapeutic drug development in transgenic malaria-resistant mosquitoes.
Besides naturally occurring AMPs and their lineages, significant antimalarial
activity has also been demonstrated in peptidomimetic compounds.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> Antimalarial peptides (AMAPs) consist of several
classes of unique peptides i.e., cationic-amphipathic host defense
peptides (defensins and cecropins),<sup><xref ref-type="bibr" rid="ref6">6</xref>−<xref ref-type="bibr" rid="ref11">11</xref></sup> membrane-active peptide antibiotics (gramicidins),<sup><xref ref-type="bibr" rid="ref12">12</xref>−<xref ref-type="bibr" rid="ref15">15</xref></sup> hydrophobic peptides (cyclosporins),<sup><xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup> thiopeptides
(thiostrepton),<sup><xref ref-type="bibr" rid="ref17">17</xref>−<xref ref-type="bibr" rid="ref19">19</xref></sup> and other natural or synthetic peptides. The aforementioned
peptides are involved in membrane interactions that are more specific
to the parasite membranes than the host cellular membrane, and some
are thought to have more specific intracellular targets.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> Hence, AMPs play an important role of innate
immunity in the host defense mechanism against infections. Most AMPs
are encompass cationic molecules at physiological pH and amphipathic
peptides that are smaller than 45–50 amino acid residues.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> In addition, an in vitro study on the antiplasmodial
activity of fungal-derived peptide antibiotics has also been reported.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup></p>
    <p>As such, accurate identification of AMAPs
will give a direction
for elucidating and revealing their potential functional mechanisms.
To date, two computational techniques, including molecular docking
and molecular dynamics (MD) simulations, have been used in the discovery
of new AMAPs or antiplasmodial peptides. Both molecular docking and
MD simulations were able to elucidate the interactions between novel
phenylalanine–glycine dipeptide sulfonamide conjugate compounds
and target protein residues.<sup><xref ref-type="bibr" rid="ref22">22</xref>−<xref ref-type="bibr" rid="ref24">24</xref></sup> To validate the antiplasmodial
activity of cyclic peptides engineered from phytocystatin against
falcipain (cysteine proteases from the malarial parasite <italic>P. falciparum</italic>), protein–peptide docking and
MD simulations were performed to calculate the free energy of ligand–enzyme
binding.<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref26">26</xref></sup> Moreover, MD experiments of the interaction
between a potential drug target PFI1625c (a metalloprotease present
in <italic>P. falciparum</italic>) and several bioactive
peptides have been performed to screen for AMAPs with high affinity.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> Although these two computational techniques
could enable the discovery of new AMAPs, all these approaches might
be limited in the large-scale identification of new AMAPs from a vast
number of candidate peptides. Thus, with such potential of AMAPs in
therapeutic applications, automated machine learning (ML)-based approaches
that can rapidly and accurately identify AMAPs by using only sequence
information are highly desirable.</p>
    <p>In this study, we present
a new computational approach (named iAMAP-SCM)
that is able to rapidly identify AMAPs and automatically generate
propensities of 20 amino acids and 400 dipeptides to be AMAPs. To
the best of our knowledge, iAMAP-SCM is the first scoring card method
(SCM)-based model for AMAP identification and characterization. In
iAMAP-SCM, we established a benchmark dataset by collecting experimentally
validated AMAPs and non-AMAPs extracted from several resources. Then,
propensities of 20 amino acids and 400 dipeptides were estimated and
optimized using the 10-fold cross-validation scheme. After that, the
estimated propensities of 20 amino acids were utilized to select important
physicochemical properties (PCPs) from the amino acid index database
(AAindex). Finally, the optimal propensities of 400 dipeptides (DPS)
were selected and used to develop the final predictive model (iAMAP-SCM).
Experimental results on the independent test dataset showed that iAMAP-SCM
could achieve a maximum accuracy (ACC) and Matthew’s coefficient
correlation(MCC) of 0.957 and 0.834, respectively. In addition, comparative
analysis results revealed that iAMAP-SCM outperformed decision tree
(DT)-based, k-nearest neighbor (KNN)-based, and logistic regression
(LR)-based classifiers as indicated by MCC and balanced accuracy (BACC)
on both the training and independent test datasets. Furthermore, analysis
results based on the 20 amino acid propensities and selected PCPs
indicated four important characteristics of AMAPs, which can be encapsulated
as follows: (i) AMAPs have high conformational and thermal stability;
(ii) AMAPs are composed of hydrophobic amino acids; (iii) AMAPs are
composed of amino acids interacting with the cell membrane; and (iv)
AMAPs tend to be in the amphipathic antimicrobial peptide class.</p>
  </sec>
  <sec id="sec2">
    <label>2</label>
    <title>Materials and Methods</title>
    <sec id="sec2.1">
      <label>2.1</label>
      <title>Dataset Preparation</title>
      <p>Dataset preparation
is an important step in the development of ML-based models. Herein,
we created two datasets called main and alternative datasets. To be
specific, positive samples were experimentally validated AMAPs, which
were mainly derived from ParaPep<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> and
several literature studies.<sup><xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref29">29</xref>−<xref ref-type="bibr" rid="ref33">33</xref></sup> After removing redundant samples, a total of 139 unique AMAPs were
accounted for in this study. These AMAPs were then used for creating
the main and alternative datasets. Since there are very few experimentally
validated non-AMAPs, negative samples in the main dataset were derived
from non-parasitic peptides, which were derived from the work of Xiao
et al.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> For the alterative dataset, negative
samples were derived from random peptides in SwissProt, which were
derived from the work of Agrawal et al.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> Herein, we excluded the negative samples found in both main and
alterative datasets. As a result, the main dataset consisted of 139
positives and 2135 negatives, while the alternative dataset consisted
of 139 positives and 677 negatives.</p>
    </sec>
    <sec id="sec2.2">
      <label>2.2</label>
      <title>Construction of Training and Independent Test
Datasets</title>
      <p>Herein, around 80% of positive and negative samples
were used for constructing the training dataset, while the remaining
were considered for constructing the independent test dataset.</p>
      <p>In general, the training dataset is employed for model construction
and optimization, while the independent test dataset is employed to
evaluate the effectiveness and generalizability of the model. Therefore,
for the main dataset, its training and independent test datasets (referred
herein as Main-CV and Main-TS, respectively) contained (111 positives
and 1708 negatives) and (28 positives and 427 negatives), respectively.
In the same way, the training and independent test datasets of the
alternative dataset (referred herein as Alter-CV and Alter-TS, respectively)
contained (111 positives and 542 negatives) and (28 positives and
135 negatives), respectively. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04465/suppl_file/ao2c04465_si_001.pdf">Table S1</ext-link> summarizes
the details of the Main-CV, Main-TS, Alter-CV, and Alter-TS datasets.
Herein, we noticed that most of the AMAPs contain less than 30 amino
acid residues (87.27%), while most of the non-AMAPs contain less than
40 amino acid residues (72.19 and 73.62% for the Main-CV and Alter-CV
datasets, respectively) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04465/suppl_file/ao2c04465_si_001.pdf">Tables S2 and S3</ext-link>).</p>
    </sec>
    <sec id="sec2.3">
      <label>2.3</label>
      <title>General Framework of iAMAP-SCM</title>
      <p>Here,
iAMAP-SCM is an SCM-based predictor coupled with the optimal propensities
of 400 dipeptides designed for AMAP prediction and characterization.
Numerous previous studies demonstrated that the SCM method iAMAP-SCM
is able to rapidly identify several biological functions of peptides
and automatically generate propensities of 20 amino acids and 400
dipeptides as a function of interest in a supervised manner.<sup><xref ref-type="bibr" rid="ref36">36</xref>−<xref ref-type="bibr" rid="ref41">41</xref></sup> The iAMAP-SCM construction involves three main steps (as summarized
in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>), which
involves the generation of an initial propensity score of 400 dipeptides
(init – DPS), DPS optimization, iAMAP-SCM construction, and
AMAP characterization using informative PCPs from the AAindex database.
Below, we briefly describe the calculation and optimization procedures
of the DPS. In the meanwhile, the propensities of 400 <italic>g</italic>-gap dipeptides (GDPS) (<italic>g = i</italic>, where <italic>i =</italic> 1, 2, 3, 4, and 5) can be optimized in the same procedure as the
DPS.</p>
      <fig id="fig1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Schematic framework of the development of iAMAP-SCM. The schematic
framework of the development of SCMB3PP contains four main steps:
(i) training and independent dataset preparation, (ii) DPS generation
and optimization, (iii) iAMAP-SCM construction, and (iv) performance
evaluation.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_0002" id="gr1" position="float"/>
      </fig>
      <sec id="sec2.3.1">
        <label>2.3.1</label>
        <title>Generating Init-DPS</title>
        <p>We generated
an initial-DPS matrix (init – DPS<sub><italic>ij</italic></sub> = {<italic>n<sub>ij</sub></italic>}) using a simple statistical
method, where <italic>n<sub>ij</sub></italic> is the number of occurrences
of the dipeptides containing the <italic>i</italic><sup>th</sup> amino
acid followed by the <italic>j</italic><sup>th</sup> amino acid, where <italic>i</italic>, <italic>j</italic> = 1,2,3, ...,20. The first step is
to calculate the number of occurrences of 400 dipeptides in positive
(<italic>P<sub>ij</sub></italic> = (<italic>n<sub>ij</sub></italic> | <italic>C</italic> = 1)) and negative (<italic>N<sub>ij</sub></italic> = (<italic>n<sub>ij</sub></italic> | <italic>C</italic> = 0)) samples.
The second step is to compute the composition of <italic>P<sub>ij</sub></italic> and <italic>N<sub>ij</sub></italic>, which are referred
to as <italic>cP<sub>ij</sub></italic> and <italic>cN<sub>ij</sub></italic>. The third step is to compute the scores of 400 dipeptides
by subtracting <italic>cP<sub>ij</sub></italic> from <italic>cN<sub>ij</sub></italic>. Finally, the scores of 400 dipeptides are normalized
into the range of 0–1000 to construct the init – DPS,
which is a 20 × 20 matrix containing initial propensity scores
of 400 dipeptides.</p>
      </sec>
      <sec id="sec2.3.2">
        <label>2.3.2</label>
        <title>Optimizing DPS</title>
        <p>Since the information
of init – DPS might be not sufficient to enable the construction
of a comprehensive predictive model,<sup><xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> we employed the genetic algorithm (GA) to create
the DPS matrix, which is a 20 × 20 matrix containing optimal
propensity scores of 400 dipeptides. The major contribution of the
DPS over init – DPS could be listed as follows: (i) the DPS
could enhance the discriminative ability and (ii) the DPS could conserve
the information of AMAPs. In this work, the fitness function of the
GA algorithm is represented by<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_m001" position="anchor"/><label>1</label></disp-formula></p>
        <p>As can be seen, this
fitness function involves the area under the receiver operating characteristics
(ROC) curve (AUC) and Pearson’s correlation coefficient (<italic>R</italic>-value) between DPS and init – DPS.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref38">38</xref></sup> To control overfitting and biasness, we assessed the predictive
performance of each DPS by the 10-fold cross-validation scheme. More
details of the DPS optimization is summarized in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04465/suppl_file/ao2c04465_si_001.pdf">Supplementary Methods</ext-link>.</p>
      </sec>
      <sec id="sec2.3.3">
        <label>2.3.3</label>
        <title>Constructing iAMAP-SCM</title>
        <p>In this
step, we aimed to construct a scoring function <italic>S</italic>(<italic>P</italic>) coupled with the DPS and to determine an optimal threshold
value. As a result, the scoring function <italic>S</italic>(<italic>P</italic>) used for AMAP identification is defined as follows:<disp-formula id="eq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_m002" position="anchor"/><label>2</label></disp-formula>where <italic>S<sub>i</sub></italic> and DPS<sub><italic>i</italic></sub> represent the occurrence
number and the propensity score of the <italic>i</italic><sup>th</sup> dipeptide. The query peptide <italic>P</italic> is considered as
AMAP, if <italic>S</italic>(<italic>P</italic>) is greater than the
threshold value, otherwise the query peptide <italic>P</italic> is
considered as non-AMAP<disp-formula id="eq3"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_m003" position="anchor"/><label>3</label></disp-formula></p>
        <p>The DPS having the
highest MCC were considered for constructing the final model (iAMAP-SCM).
More detailed information for the SCM method and tDPS optimization
is recorded in our previous studies.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup></p>
      </sec>
      <sec id="sec2.3.4">
        <label>2.3.4</label>
        <title>AMAP Characterization Using Informative
PCPs</title>
        <p>After obtaining the optimal DPS, the propensity score
of the <italic>i</italic><sup>th</sup> amino acid is computed by averaging
the propensity scores of all dipeptides containing the <italic>i</italic><sup>th</sup> amino acid. These propensities were then utilized to
select informative PCPs relating to functional mechanisms of AMAPs.
To select informative PCPs, first, we collected 544 PCPs from the
AAindex database<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> and the PCPs having
a value of “NA” were eliminated to optimize the utilization
of PCPs. As a result, the remaining 531 PCPs were employed herein.
Second, we calculated the <italic>R</italic>-value between the propensities
of the 20 amino acids and each of the 531PCPs. Finally, we selected
the top 20 informative PCPs with the highest <italic>R</italic>-values
for AMAP characterization.</p>
      </sec>
    </sec>
    <sec id="sec2.4">
      <label>2.4</label>
      <title>Conventional ML-Based Classifiers</title>
      <p>In this study, a total of 72 different ML classifiers (8 MLs ×
9 descriptors) were created by using eight popular ML algorithms (DT,
KNN, LR, multilayer perceptron (MLP), naive Bayes (NB), partial least
squares regression (PLS), random forest (RF), and support vector machine
(SVM)) trained with nine conventional feature descriptors (AAindex,
PCP, amino acid composition (AAC), composition transition and distribution
(CTD), composition (CTDC), distribution (CTDD), transition (CTDT),
dipeptide composition (DPC), and tripeptide composition (TPC)). For
implementation, all the 72 ML classifiers were trained and optimized
under the 10-fold cross-validation test based on the iFeature<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> and the Scikit-learn v0.22.0 packages<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04465/suppl_file/ao2c04465_si_001.pdf">Table S4</ext-link>). A detailed
description of the construction of these ML classifiers is recorded
in our previous reports.<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref>,<xref ref-type="bibr" rid="ref47">47</xref>,<xref ref-type="bibr" rid="ref48">48</xref></sup></p>
    </sec>
    <sec id="sec2.5">
      <label>2.5</label>
      <title>Evaluation Metrics</title>
      <p>The performance
of iAMAP-SCM and conventional ML classifiers was evaluated in terms
of five well-known performance measures, including ACC, AUC, BACC,
MCC, sensitivity (Sn), specificity (Sp), and area under the precision-recall
(PR) curve (AUPR),<sup><xref ref-type="bibr" rid="ref47">47</xref>,<xref ref-type="bibr" rid="ref49">49</xref></sup> described as follows:<disp-formula id="eq4"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_m004" position="anchor"/><label>4</label></disp-formula><disp-formula id="eq5"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_m005" position="anchor"/><label>5</label></disp-formula><disp-formula id="eq6"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_m006" position="anchor"/><label>6</label></disp-formula><disp-formula id="eq7"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_m007" position="anchor"/><label>7</label></disp-formula><disp-formula id="eq8"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_m008" position="anchor"/><label>8</label></disp-formula>where TPs and TNs represent
the number of true AMAPs and true non-AMAPs that are correctly predicted
as AMAPs and non-AMAPs, respectively. On the other hand, FPs and FNs
represent the number of true non-AMAPs and true AMAPs that are predicted
as AMAPs and true non-AMAPs, respectively.<sup><xref ref-type="bibr" rid="ref50">50</xref>−<xref ref-type="bibr" rid="ref54">54</xref></sup></p>
    </sec>
  </sec>
  <sec id="sec3">
    <label>3</label>
    <title>Results and Discussion</title>
    <sec id="sec3.1">
      <label>3.1</label>
      <title>Performance Evaluation of BLAST-Based Predictors</title>
      <p>In this section, we created a BLAST-based predictor for the prediction
of AMAPs. A detailed construction of the BLAST-based predictor is
summarized in our previous studies.<sup><xref ref-type="bibr" rid="ref55">55</xref>,<xref ref-type="bibr" rid="ref56">56</xref></sup> To assess
the performance of BLAST-based predictors, the expectation values
(<italic>E</italic>-values) in the range of 0.0001 to 0.1 were employed. <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> provides the performance
comparison results of various <italic>E</italic>-values on the Main-TS
and Alter-TS datasets. The highest ACC values of 0.901 and 0.889 on
the Main-TS and Alter-TS datasets were achieved using <italic>E</italic>-value cutoff values of 0.0001 and 0.1, respectively. However, these
cutoff values were found to have Sn values of 0.222 and 0.407 on the
Main-TS and Alter-TS datasets, respectively, thereby indicating that
the BLAST-based predictor was not effective for accurately identifying
true AMAPs. Altogether, ML-based predictors that are capable of accurately
and rapidly identifying AMAPs are more suitable for this problem.</p>
      <table-wrap id="tbl1" position="float">
        <label>Table 1</label>
        <caption>
          <title>Performance Evaluation of BLAST-Based
Predictors Using Various <italic>E</italic>-Value Cutoffs</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">dataset</th>
              <th style="border:none;" align="center" char="."><italic>E</italic>-value</th>
              <th style="border:none;" align="center" char=".">ACC</th>
              <th style="border:none;" align="center" char=".">BACC</th>
              <th style="border:none;" align="center" char=".">Sn</th>
              <th style="border:none;" align="center" char=".">Sp</th>
              <th style="border:none;" align="center" char=".">MCC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">Main-TS</td>
              <td style="border:none;" align="char" char=".">0.1</td>
              <td style="border:none;" align="char" char=".">0.824</td>
              <td style="border:none;" align="char" char=".">0.629</td>
              <td style="border:none;" align="char" char=".">0.407</td>
              <td style="border:none;" align="char" char=".">0.850</td>
              <td style="border:none;" align="char" char=".">0.164</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="char" char=".">0.01</td>
              <td style="border:none;" align="char" char=".">0.872</td>
              <td style="border:none;" align="char" char=".">0.602</td>
              <td style="border:none;" align="char" char=".">0.296</td>
              <td style="border:none;" align="char" char=".">0.909</td>
              <td style="border:none;" align="char" char=".">0.159</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="char" char=".">0.001</td>
              <td style="border:none;" align="char" char=".">0.892</td>
              <td style="border:none;" align="char" char=".">0.596</td>
              <td style="border:none;" align="char" char=".">0.259</td>
              <td style="border:none;" align="char" char=".">0.932</td>
              <td style="border:none;" align="char" char=".">0.167</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="char" char=".">0.0001</td>
              <td style="border:none;" align="char" char=".">0.901</td>
              <td style="border:none;" align="char" char=".">0.583</td>
              <td style="border:none;" align="char" char=".">0.222</td>
              <td style="border:none;" align="char" char=".">0.944</td>
              <td style="border:none;" align="char" char=".">0.158</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Alter-TS</td>
              <td style="border:none;" align="char" char=".">0.1</td>
              <td style="border:none;" align="char" char=".">0.889</td>
              <td style="border:none;" align="char" char=".">0.696</td>
              <td style="border:none;" align="char" char=".">0.407</td>
              <td style="border:none;" align="char" char=".">0.985</td>
              <td style="border:none;" align="char" char=".">0.539</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="char" char=".">0.01</td>
              <td style="border:none;" align="char" char=".">0.883</td>
              <td style="border:none;" align="char" char=".">0.648</td>
              <td style="border:none;" align="char" char=".">0.296</td>
              <td style="border:none;" align="char" char=".">1.000</td>
              <td style="border:none;" align="char" char=".">0.510</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="char" char=".">0.001</td>
              <td style="border:none;" align="char" char=".">0.877</td>
              <td style="border:none;" align="char" char=".">0.630</td>
              <td style="border:none;" align="char" char=".">0.259</td>
              <td style="border:none;" align="char" char=".">1.000</td>
              <td style="border:none;" align="char" char=".">0.475</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="char" char=".">0.0001</td>
              <td style="border:none;" align="char" char=".">0.870</td>
              <td style="border:none;" align="char" char=".">0.611</td>
              <td style="border:none;" align="char" char=".">0.222</td>
              <td style="border:none;" align="char" char=".">1.000</td>
              <td style="border:none;" align="char" char=".">0.439</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="sec3.2">
      <label>3.2</label>
      <title>Performance Evaluation of Different Sets of
Propensity Scores</title>
      <p>Here, we evaluated and analyzed the predictive
capability of variant SCM classifiers coupled with six different types
of propensity scores by performing 10-fold cross-validation and independent
tests on both the main and alternative datasets. <xref rid="tbl2" ref-type="other">Tables <xref rid="tbl2" ref-type="other">2</xref></xref> and <xref rid="tbl3" ref-type="other">3</xref> list a comparison of the predictive performance of the six different
types of propensity scores. <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> shows that the highest MCC of 0.793 in terms of the
Main-CV dataset is achieved by using DPS, while the second and third
highest MCC of 0.765 are obtained from GDPS (<italic>g</italic> =
1) and GDPS (<italic>g</italic> = 4). Interestingly, we noticed that
the best-performing DPS also accomplished satisfactory results with
the highest MCC of 0.776 on the Main-TS dataset. For the performance
on the alternative dataset, we noticed that DPS performed well with
the highest MCC of 0.917 on the Alter-CV dataset (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>), while GDPS (<italic>g</italic> = 1) performed well with the third highest MCC of 0.900. Remarkably,
DPS still yielded an impressive predictive performance with an MCC
of 0.834 on the Alter-TS dataset. Altogether, our comparative results
highlighted the importance and contribution of DPS to the performance
of the SCM classifier. Thus, for the convenience of discussion, the
SCM classifiers combined with DPS is referred to as iAMAP-SCM. The
propensities of 400 dipeptides based on threshold values of 449 and
309 on the Main-CV and Alter-CV datasets, respectively, are shown
in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>.</p>
      <fig id="fig2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Propensity
scores of 20 amino acids to be AMAPs obtained from the
proposed iAMAP-SCM based on the Main-CV (A) and Alter-CV (B) datasets.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_0003" id="gr2" position="float"/>
      </fig>
      <table-wrap id="tbl2" position="float">
        <label>Table 2</label>
        <caption>
          <title>Performance Comparison of Different
Types of Propensity Scores on the Main Dataset</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">dataset</th>
              <th style="border:none;" align="center">descriptor</th>
              <th style="border:none;" align="center">cutoff</th>
              <th style="border:none;" align="center" char=".">ACC</th>
              <th style="border:none;" align="center" char=".">BACC</th>
              <th style="border:none;" align="center" char=".">Sn</th>
              <th style="border:none;" align="center" char=".">Sp</th>
              <th style="border:none;" align="center" char=".">MCC</th>
              <th style="border:none;" align="center" char=".">AUC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">Main-CV</td>
              <td style="border:none;" align="left">DPS</td>
              <td style="border:none;" align="left">449</td>
              <td style="border:none;" align="char" char=".">0.978</td>
              <td style="border:none;" align="char" char=".">0.857</td>
              <td style="border:none;" align="char" char=".">0.720</td>
              <td style="border:none;" align="char" char=".">0.995</td>
              <td style="border:none;" align="char" char=".">0.793</td>
              <td style="border:none;" align="char" char=".">0.881</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 1)</td>
              <td style="border:none;" align="left">424</td>
              <td style="border:none;" align="char" char=".">0.978</td>
              <td style="border:none;" align="char" char=".">0.852</td>
              <td style="border:none;" align="char" char=".">0.710</td>
              <td style="border:none;" align="char" char=".">0.994</td>
              <td style="border:none;" align="char" char=".">0.765</td>
              <td style="border:none;" align="char" char=".">0.924</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 2)</td>
              <td style="border:none;" align="left">540</td>
              <td style="border:none;" align="char" char=".">0.978</td>
              <td style="border:none;" align="char" char=".">0.840</td>
              <td style="border:none;" align="char" char=".">0.687</td>
              <td style="border:none;" align="char" char=".">0.994</td>
              <td style="border:none;" align="char" char=".">0.760</td>
              <td style="border:none;" align="char" char=".">0.911</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 3)</td>
              <td style="border:none;" align="left">513</td>
              <td style="border:none;" align="char" char=".">0.980</td>
              <td style="border:none;" align="char" char=".">0.820</td>
              <td style="border:none;" align="char" char=".">0.643</td>
              <td style="border:none;" align="char" char=".">0.997</td>
              <td style="border:none;" align="char" char=".">0.759</td>
              <td style="border:none;" align="char" char=".">0.899</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 4)</td>
              <td style="border:none;" align="left">478</td>
              <td style="border:none;" align="char" char=".">0.980</td>
              <td style="border:none;" align="char" char=".">0.814</td>
              <td style="border:none;" align="char" char=".">0.631</td>
              <td style="border:none;" align="char" char=".">0.998</td>
              <td style="border:none;" align="char" char=".">0.765</td>
              <td style="border:none;" align="char" char=".">0.897</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 5)</td>
              <td style="border:none;" align="left">586</td>
              <td style="border:none;" align="char" char=".">0.979</td>
              <td style="border:none;" align="char" char=".">0.783</td>
              <td style="border:none;" align="char" char=".">0.568</td>
              <td style="border:none;" align="char" char=".">0.998</td>
              <td style="border:none;" align="char" char=".">0.709</td>
              <td style="border:none;" align="char" char=".">0.854</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Main-TS</td>
              <td style="border:none;" align="left">DPS</td>
              <td style="border:none;" align="left">449</td>
              <td style="border:none;" align="char" char=".">0.978</td>
              <td style="border:none;" align="char" char=".">0.826</td>
              <td style="border:none;" align="char" char=".">0.654</td>
              <td style="border:none;" align="char" char=".">0.998</td>
              <td style="border:none;" align="char" char=".">0.776</td>
              <td style="border:none;" align="char" char=".">0.820</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 1)</td>
              <td style="border:none;" align="left">424</td>
              <td style="border:none;" align="char" char=".">0.967</td>
              <td style="border:none;" align="char" char=".">0.775</td>
              <td style="border:none;" align="char" char=".">0.560</td>
              <td style="border:none;" align="char" char=".">0.991</td>
              <td style="border:none;" align="char" char=".">0.644</td>
              <td style="border:none;" align="char" char=".">0.856</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 2)</td>
              <td style="border:none;" align="left">540</td>
              <td style="border:none;" align="char" char=".">0.971</td>
              <td style="border:none;" align="char" char=".">0.769</td>
              <td style="border:none;" align="char" char=".">0.545</td>
              <td style="border:none;" align="char" char=".">0.993</td>
              <td style="border:none;" align="char" char=".">0.647</td>
              <td style="border:none;" align="char" char=".">0.798</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 3)</td>
              <td style="border:none;" align="left">513</td>
              <td style="border:none;" align="char" char=".">0.982</td>
              <td style="border:none;" align="char" char=".">0.824</td>
              <td style="border:none;" align="char" char=".">0.650</td>
              <td style="border:none;" align="char" char=".">0.998</td>
              <td style="border:none;" align="char" char=".">0.769</td>
              <td style="border:none;" align="char" char=".">0.865</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 4)</td>
              <td style="border:none;" align="left">478</td>
              <td style="border:none;" align="char" char=".">0.973</td>
              <td style="border:none;" align="char" char=".">0.795</td>
              <td style="border:none;" align="char" char=".">0.600</td>
              <td style="border:none;" align="char" char=".">0.991</td>
              <td style="border:none;" align="char" char=".">0.657</td>
              <td style="border:none;" align="char" char=".">0.850</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 5)</td>
              <td style="border:none;" align="left">586</td>
              <td style="border:none;" align="char" char=".">0.980</td>
              <td style="border:none;" align="char" char=".">0.777</td>
              <td style="border:none;" align="char" char=".">0.556</td>
              <td style="border:none;" align="char" char=".">0.998</td>
              <td style="border:none;" align="char" char=".">0.702</td>
              <td style="border:none;" align="char" char=".">0.819</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="tbl3" position="float">
        <label>Table 3</label>
        <caption>
          <title>Performance Comparison of Different
Types of Propensity Scores on the Alternative Dataset</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">dataset</th>
              <th style="border:none;" align="center">descriptor</th>
              <th style="border:none;" align="center">cutoff</th>
              <th style="border:none;" align="center" char=".">ACC</th>
              <th style="border:none;" align="center" char=".">BACC</th>
              <th style="border:none;" align="center" char=".">Sn</th>
              <th style="border:none;" align="center" char=".">Sp</th>
              <th style="border:none;" align="center" char=".">MCC</th>
              <th style="border:none;" align="center" char=".">AUC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">Alter-CV</td>
              <td style="border:none;" align="left">DPS</td>
              <td style="border:none;" align="left">309</td>
              <td style="border:none;" align="char" char=".">0.977</td>
              <td style="border:none;" align="char" char=".">0.950</td>
              <td style="border:none;" align="char" char=".">0.910</td>
              <td style="border:none;" align="char" char=".">0.991</td>
              <td style="border:none;" align="char" char=".">0.917</td>
              <td style="border:none;" align="char" char=".">0.968</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 1)</td>
              <td style="border:none;" align="left">423</td>
              <td style="border:none;" align="char" char=".">0.975</td>
              <td style="border:none;" align="char" char=".">0.935</td>
              <td style="border:none;" align="char" char=".">0.877</td>
              <td style="border:none;" align="char" char=".">0.993</td>
              <td style="border:none;" align="char" char=".">0.900</td>
              <td style="border:none;" align="char" char=".">0.957</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 2)</td>
              <td style="border:none;" align="left">390</td>
              <td style="border:none;" align="char" char=".">0.972</td>
              <td style="border:none;" align="char" char=".">0.925</td>
              <td style="border:none;" align="char" char=".">0.860</td>
              <td style="border:none;" align="char" char=".">0.991</td>
              <td style="border:none;" align="char" char=".">0.886</td>
              <td style="border:none;" align="char" char=".">0.943</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 3)</td>
              <td style="border:none;" align="left">312</td>
              <td style="border:none;" align="char" char=".">0.979</td>
              <td style="border:none;" align="char" char=".">0.940</td>
              <td style="border:none;" align="char" char=".">0.885</td>
              <td style="border:none;" align="char" char=".">0.994</td>
              <td style="border:none;" align="char" char=".">0.912</td>
              <td style="border:none;" align="char" char=".">0.971</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 4)</td>
              <td style="border:none;" align="left">329</td>
              <td style="border:none;" align="char" char=".">0.968</td>
              <td style="border:none;" align="char" char=".">0.915</td>
              <td style="border:none;" align="char" char=".">0.840</td>
              <td style="border:none;" align="char" char=".">0.989</td>
              <td style="border:none;" align="char" char=".">0.862</td>
              <td style="border:none;" align="char" char=".">0.962</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 5)</td>
              <td style="border:none;" align="left">418</td>
              <td style="border:none;" align="char" char=".">0.958</td>
              <td style="border:none;" align="char" char=".">0.884</td>
              <td style="border:none;" align="char" char=".">0.784</td>
              <td style="border:none;" align="char" char=".">0.983</td>
              <td style="border:none;" align="char" char=".">0.806</td>
              <td style="border:none;" align="char" char=".">0.935</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Alter-TS</td>
              <td style="border:none;" align="left">DPS</td>
              <td style="border:none;" align="left">309</td>
              <td style="border:none;" align="char" char=".">0.957</td>
              <td style="border:none;" align="char" char=".">0.896</td>
              <td style="border:none;" align="char" char=".">0.808</td>
              <td style="border:none;" align="char" char=".">0.985</td>
              <td style="border:none;" align="char" char=".">0.834</td>
              <td style="border:none;" align="char" char=".">0.903</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 1)</td>
              <td style="border:none;" align="left">423</td>
              <td style="border:none;" align="char" char=".">0.956</td>
              <td style="border:none;" align="char" char=".">0.876</td>
              <td style="border:none;" align="char" char=".">0.760</td>
              <td style="border:none;" align="char" char=".">0.993</td>
              <td style="border:none;" align="char" char=".">0.826</td>
              <td style="border:none;" align="char" char=".">0.873</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 2)</td>
              <td style="border:none;" align="left">390</td>
              <td style="border:none;" align="char" char=".">0.943</td>
              <td style="border:none;" align="char" char=".">0.834</td>
              <td style="border:none;" align="char" char=".">0.682</td>
              <td style="border:none;" align="char" char=".">0.985</td>
              <td style="border:none;" align="char" char=".">0.745</td>
              <td style="border:none;" align="char" char=".">0.799</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 3)</td>
              <td style="border:none;" align="left">312</td>
              <td style="border:none;" align="char" char=".">0.974</td>
              <td style="border:none;" align="char" char=".">0.900</td>
              <td style="border:none;" align="char" char=".">0.800</td>
              <td style="border:none;" align="char" char=".">1.000</td>
              <td style="border:none;" align="char" char=".">0.881</td>
              <td style="border:none;" align="char" char=".">0.948</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 4)</td>
              <td style="border:none;" align="left">329</td>
              <td style="border:none;" align="char" char=".">0.942</td>
              <td style="border:none;" align="char" char=".">0.839</td>
              <td style="border:none;" align="char" char=".">0.700</td>
              <td style="border:none;" align="char" char=".">0.978</td>
              <td style="border:none;" align="char" char=".">0.727</td>
              <td style="border:none;" align="char" char=".">0.911</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">GDPS (<italic>g</italic> = 5)</td>
              <td style="border:none;" align="left">418</td>
              <td style="border:none;" align="char" char=".">0.967</td>
              <td style="border:none;" align="char" char=".">0.885</td>
              <td style="border:none;" align="char" char=".">0.778</td>
              <td style="border:none;" align="char" char=".">0.993</td>
              <td style="border:none;" align="char" char=".">0.835</td>
              <td style="border:none;" align="char" char=".">0.941</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>As mentioned in the General <xref rid="sec2.3" ref-type="other">Framework
of iAMAP-SCM</xref> Section, the GA method was used to optimize the
initial propensity
scores as means to improve the performance of the SCM classifier.
To elucidate this important point, we compared the predictive performance
of DPS to that of initial-DPS (<xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref>). It could be noticed that DPS yielded the overall
best performance as compared with initial-DPS as judged by all measures
on both the 10-fold cross-validation and independent tests. To be
specific, the BACC and MCC of DPS were 2.2–6.0 and 7.0–17.3%
higher than those of the initial-DPS, respectively, on the Main-TS
and Alter-TS datasets. Altogether, our analysis results confirmed
that the propensities of 400 dipeptides (DPS) provide more discriminative
power for identifying AMAPs than initial-DPS.</p>
      <table-wrap id="tbl4" position="float">
        <label>Table 4</label>
        <caption>
          <title>Performance Comparison of DPS with
Initial-DPS on the Main and Alternative Datasets</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">dataset</th>
              <th style="border:none;" align="center">descriptor</th>
              <th style="border:none;" align="center" char=".">ACC</th>
              <th style="border:none;" align="center" char=".">BACC</th>
              <th style="border:none;" align="center" char=".">Sn</th>
              <th style="border:none;" align="center" char=".">Sp</th>
              <th style="border:none;" align="center" char=".">MCC</th>
              <th style="border:none;" align="center" char=".">AUC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">Main-CV</td>
              <td style="border:none;" align="left">Initial-DPS</td>
              <td style="border:none;" align="char" char=".">0.958</td>
              <td style="border:none;" align="char" char=".">0.757</td>
              <td style="border:none;" align="char" char=".">0.530</td>
              <td style="border:none;" align="char" char=".">0.985</td>
              <td style="border:none;" align="char" char=".">0.588</td>
              <td style="border:none;" align="char" char=".">0.895</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">DPS</td>
              <td style="border:none;" align="char" char=".">0.978</td>
              <td style="border:none;" align="char" char=".">0.857</td>
              <td style="border:none;" align="char" char=".">0.720</td>
              <td style="border:none;" align="char" char=".">0.995</td>
              <td style="border:none;" align="char" char=".">0.793</td>
              <td style="border:none;" align="char" char=".">0.881</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Main-TS</td>
              <td style="border:none;" align="left">Initial-DPS</td>
              <td style="border:none;" align="char" char=".">0.971</td>
              <td style="border:none;" align="char" char=".">0.804</td>
              <td style="border:none;" align="char" char=".">0.615</td>
              <td style="border:none;" align="char" char=".">0.993</td>
              <td style="border:none;" align="char" char=".">0.706</td>
              <td style="border:none;" align="char" char=".">0.776</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">DPS</td>
              <td style="border:none;" align="char" char=".">0.978</td>
              <td style="border:none;" align="char" char=".">0.826</td>
              <td style="border:none;" align="char" char=".">0.654</td>
              <td style="border:none;" align="char" char=".">0.998</td>
              <td style="border:none;" align="char" char=".">0.776</td>
              <td style="border:none;" align="char" char=".">0.820</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Alter-CV</td>
              <td style="border:none;" align="left">Initial-DPS</td>
              <td style="border:none;" align="char" char=".">0.940</td>
              <td style="border:none;" align="char" char=".">0.885</td>
              <td style="border:none;" align="char" char=".">0.801</td>
              <td style="border:none;" align="char" char=".">0.969</td>
              <td style="border:none;" align="char" char=".">0.786</td>
              <td style="border:none;" align="char" char=".">0.953</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">DPS</td>
              <td style="border:none;" align="char" char=".">0.977</td>
              <td style="border:none;" align="char" char=".">0.950</td>
              <td style="border:none;" align="char" char=".">0.910</td>
              <td style="border:none;" align="char" char=".">0.991</td>
              <td style="border:none;" align="char" char=".">0.917</td>
              <td style="border:none;" align="char" char=".">0.968</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Alter-TS</td>
              <td style="border:none;" align="left">Initial-DPS</td>
              <td style="border:none;" align="char" char=".">0.907</td>
              <td style="border:none;" align="char" char=".">0.836</td>
              <td style="border:none;" align="char" char=".">0.731</td>
              <td style="border:none;" align="char" char=".">0.941</td>
              <td style="border:none;" align="char" char=".">0.661</td>
              <td style="border:none;" align="char" char=".">0.858</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">DPS</td>
              <td style="border:none;" align="char" char=".">0.957</td>
              <td style="border:none;" align="char" char=".">0.896</td>
              <td style="border:none;" align="char" char=".">0.808</td>
              <td style="border:none;" align="char" char=".">0.985</td>
              <td style="border:none;" align="char" char=".">0.834</td>
              <td style="border:none;" align="char" char=".">0.903</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="sec3.3">
      <label>3.3</label>
      <title>Comparison of iAMAP-SCM with Conventional
ML Classifiers</title>
      <p>Since iAMAP-SCM represents the first computational
approach designed for AMAP identification, we compared its performance
to that of other conventional ML classifiers as means to elucidate
its predictive capability and effectiveness. Herein, the conventional
ML classifiers, which contained a total 72 ML classifiers trained
with eight ML algorithms and nine features were created. The performance
evaluation results of the 72 ML classifiers are recorded in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04465/suppl_file/ao2c04465_si_001.pdf">Tables S5–S8</ext-link>. Furthermore, to simplify
the comparative analysis, we compared the performance of iAMAP-SCM
to that of five top-ranked ML classifiers as determined by MCC values
on the training datasets. These comparative analysis results are provided
in <xref rid="fig3" ref-type="fig">Figures <xref rid="fig3" ref-type="fig">3</xref></xref>–<xref rid="fig5" ref-type="fig">5</xref> and <xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref>.</p>
      <fig id="fig3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Performance comparison between iAMAP-SCM and
top 20 ML classifiers.
Comparisons of MCC values on the Main-CV (A), Main-TS (B), Alter-CV
(C), and Alter-TS (D) datasets.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_0004" id="gr3" position="float"/>
      </fig>
      <fig id="fig4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Performance comparison between iAMAP-SCM and top five
ML classifiers.
Comparisons of the ROC curve, AUC value, PR curve, and AUPR value
on the Main-CV (A, B) and Main-TS (C, D) datasets.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_0005" id="gr4" position="float"/>
      </fig>
      <fig id="fig5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Performance comparison between iAMAP-SCM and top five
ML classifiers.
Comparisons of the ROC curve, AUC value, PR curve, and AUPR value
on the Alter-CV (A, B) and Alter-TS (C, D) datasets.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_0006" id="gr5" position="float"/>
      </fig>
      <table-wrap id="tbl5" position="float">
        <label>Table 5</label>
        <caption>
          <title>Performance Comparison of iAMAP-SCM
and Best-Performing ML Classifiers on the Main and Alternative Datasets</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">dataset</th>
              <th style="border:none;" align="center">method</th>
              <th style="border:none;" align="center" char=".">ACC</th>
              <th style="border:none;" align="center" char=".">BACC</th>
              <th style="border:none;" align="center" char=".">Sn</th>
              <th style="border:none;" align="center" char=".">Sp</th>
              <th style="border:none;" align="center" char=".">MCC</th>
              <th style="border:none;" align="center" char=".">AUC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">Main-CV</td>
              <td style="border:none;" align="left">MLP-TPC</td>
              <td style="border:none;" align="char" char=".">0.985</td>
              <td style="border:none;" align="char" char=".">0.894</td>
              <td style="border:none;" align="char" char=".">0.792</td>
              <td style="border:none;" align="char" char=".">0.997</td>
              <td style="border:none;" align="char" char=".">0.859</td>
              <td style="border:none;" align="char" char=".">0.944</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">SVM-TPC</td>
              <td style="border:none;" align="char" char=".">0.982</td>
              <td style="border:none;" align="char" char=".">0.868</td>
              <td style="border:none;" align="char" char=".">0.737</td>
              <td style="border:none;" align="char" char=".">0.998</td>
              <td style="border:none;" align="char" char=".">0.833</td>
              <td style="border:none;" align="char" char=".">0.919</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">LR-TPC</td>
              <td style="border:none;" align="char" char=".">0.976</td>
              <td style="border:none;" align="char" char=".">0.881</td>
              <td style="border:none;" align="char" char=".">0.773</td>
              <td style="border:none;" align="char" char=".">0.989</td>
              <td style="border:none;" align="char" char=".">0.783</td>
              <td style="border:none;" align="char" char=".">0.944</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">SVM-DPC</td>
              <td style="border:none;" align="char" char=".">0.975</td>
              <td style="border:none;" align="char" char=".">0.805</td>
              <td style="border:none;" align="char" char=".">0.611</td>
              <td style="border:none;" align="char" char=".">0.999</td>
              <td style="border:none;" align="char" char=".">0.754</td>
              <td style="border:none;" align="char" char=".">0.921</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">SVM-CTD</td>
              <td style="border:none;" align="char" char=".">0.974</td>
              <td style="border:none;" align="char" char=".">0.817</td>
              <td style="border:none;" align="char" char=".">0.638</td>
              <td style="border:none;" align="char" char=".">0.996</td>
              <td style="border:none;" align="char" char=".">0.749</td>
              <td style="border:none;" align="char" char=".">0.928</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">iAMAP-SCM</td>
              <td style="border:none;" align="char" char=".">0.978</td>
              <td style="border:none;" align="char" char=".">0.857</td>
              <td style="border:none;" align="char" char=".">0.720</td>
              <td style="border:none;" align="char" char=".">0.995</td>
              <td style="border:none;" align="char" char=".">0.793</td>
              <td style="border:none;" align="char" char=".">0.881</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Main-TS</td>
              <td style="border:none;" align="left">MLP-TPC</td>
              <td style="border:none;" align="char" char=".">0.978</td>
              <td style="border:none;" align="char" char=".">0.808</td>
              <td style="border:none;" align="char" char=".">0.615</td>
              <td style="border:none;" align="char" char=".">1.000</td>
              <td style="border:none;" align="char" char=".">0.775</td>
              <td style="border:none;" align="char" char=".">0.888</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">SVM-TPC</td>
              <td style="border:none;" align="char" char=".">0.967</td>
              <td style="border:none;" align="char" char=".">0.712</td>
              <td style="border:none;" align="char" char=".">0.423</td>
              <td style="border:none;" align="char" char=".">1.000</td>
              <td style="border:none;" align="char" char=".">0.639</td>
              <td style="border:none;" align="char" char=".">0.627</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">LR-TPC</td>
              <td style="border:none;" align="char" char=".">0.974</td>
              <td style="border:none;" align="char" char=".">0.787</td>
              <td style="border:none;" align="char" char=".">0.577</td>
              <td style="border:none;" align="char" char=".">0.998</td>
              <td style="border:none;" align="char" char=".">0.724</td>
              <td style="border:none;" align="char" char=".">0.836</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">SVM-DPC</td>
              <td style="border:none;" align="char" char=".">0.971</td>
              <td style="border:none;" align="char" char=".">0.750</td>
              <td style="border:none;" align="char" char=".">0.500</td>
              <td style="border:none;" align="char" char=".">1.000</td>
              <td style="border:none;" align="char" char=".">0.697</td>
              <td style="border:none;" align="char" char=".">0.935</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">SVM-CTD</td>
              <td style="border:none;" align="char" char=".">0.978</td>
              <td style="border:none;" align="char" char=".">0.826</td>
              <td style="border:none;" align="char" char=".">0.654</td>
              <td style="border:none;" align="char" char=".">0.998</td>
              <td style="border:none;" align="char" char=".">0.776</td>
              <td style="border:none;" align="char" char=".">0.893</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">iAMAP-SCM</td>
              <td style="border:none;" align="char" char=".">0.978</td>
              <td style="border:none;" align="char" char=".">0.826</td>
              <td style="border:none;" align="char" char=".">0.654</td>
              <td style="border:none;" align="char" char=".">0.998</td>
              <td style="border:none;" align="char" char=".">0.776</td>
              <td style="border:none;" align="char" char=".">0.820</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Alter-CV</td>
              <td style="border:none;" align="left">MLP-TPC</td>
              <td style="border:none;" align="char" char=".">0.966</td>
              <td style="border:none;" align="char" char=".">0.915</td>
              <td style="border:none;" align="char" char=".">0.837</td>
              <td style="border:none;" align="char" char=".">0.993</td>
              <td style="border:none;" align="char" char=".">0.876</td>
              <td style="border:none;" align="char" char=".">0.973</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">LR-DPC</td>
              <td style="border:none;" align="char" char=".">0.962</td>
              <td style="border:none;" align="char" char=".">0.912</td>
              <td style="border:none;" align="char" char=".">0.837</td>
              <td style="border:none;" align="char" char=".">0.987</td>
              <td style="border:none;" align="char" char=".">0.861</td>
              <td style="border:none;" align="char" char=".">0.980</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">SVM-TPC</td>
              <td style="border:none;" align="char" char=".">0.960</td>
              <td style="border:none;" align="char" char=".">0.886</td>
              <td style="border:none;" align="char" char=".">0.773</td>
              <td style="border:none;" align="char" char=".">0.998</td>
              <td style="border:none;" align="char" char=".">0.851</td>
              <td style="border:none;" align="char" char=".">0.924</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">SVM-CTD</td>
              <td style="border:none;" align="char" char=".">0.959</td>
              <td style="border:none;" align="char" char=".">0.903</td>
              <td style="border:none;" align="char" char=".">0.818</td>
              <td style="border:none;" align="char" char=".">0.987</td>
              <td style="border:none;" align="char" char=".">0.850</td>
              <td style="border:none;" align="char" char=".">0.974</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">SVM-AAC</td>
              <td style="border:none;" align="char" char=".">0.954</td>
              <td style="border:none;" align="char" char=".">0.929</td>
              <td style="border:none;" align="char" char=".">0.891</td>
              <td style="border:none;" align="char" char=".">0.967</td>
              <td style="border:none;" align="char" char=".">0.844</td>
              <td style="border:none;" align="char" char=".">0.983</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">iAMAP-SCM</td>
              <td style="border:none;" align="char" char=".">0.977</td>
              <td style="border:none;" align="char" char=".">0.950</td>
              <td style="border:none;" align="char" char=".">0.910</td>
              <td style="border:none;" align="char" char=".">0.991</td>
              <td style="border:none;" align="char" char=".">0.917</td>
              <td style="border:none;" align="char" char=".">0.968</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Alter-TS</td>
              <td style="border:none;" align="left">MLP-TPC</td>
              <td style="border:none;" align="char" char=".">0.950</td>
              <td style="border:none;" align="char" char=".">0.846</td>
              <td style="border:none;" align="char" char=".">0.692</td>
              <td style="border:none;" align="char" char=".">1.000</td>
              <td style="border:none;" align="char" char=".">0.808</td>
              <td style="border:none;" align="char" char=".">0.920</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">LR-DPC</td>
              <td style="border:none;" align="char" char=".">0.950</td>
              <td style="border:none;" align="char" char=".">0.877</td>
              <td style="border:none;" align="char" char=".">0.769</td>
              <td style="border:none;" align="char" char=".">0.985</td>
              <td style="border:none;" align="char" char=".">0.808</td>
              <td style="border:none;" align="char" char=".">0.944</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">SVM-TPC</td>
              <td style="border:none;" align="char" char=".">0.907</td>
              <td style="border:none;" align="char" char=".">0.727</td>
              <td style="border:none;" align="char" char=".">0.462</td>
              <td style="border:none;" align="char" char=".">0.993</td>
              <td style="border:none;" align="char" char=".">0.613</td>
              <td style="border:none;" align="char" char=".">0.630</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">SVM-CTD</td>
              <td style="border:none;" align="char" char=".">0.963</td>
              <td style="border:none;" align="char" char=".">0.916</td>
              <td style="border:none;" align="char" char=".">0.846</td>
              <td style="border:none;" align="char" char=".">0.985</td>
              <td style="border:none;" align="char" char=".">0.859</td>
              <td style="border:none;" align="char" char=".">0.966</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">SVM-AAC</td>
              <td style="border:none;" align="char" char=".">0.932</td>
              <td style="border:none;" align="char" char=".">0.882</td>
              <td style="border:none;" align="char" char=".">0.808</td>
              <td style="border:none;" align="char" char=".">0.956</td>
              <td style="border:none;" align="char" char=".">0.752</td>
              <td style="border:none;" align="char" char=".">0.967</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">iAMAP-SCM</td>
              <td style="border:none;" align="char" char=".">0.957</td>
              <td style="border:none;" align="char" char=".">0.896</td>
              <td style="border:none;" align="char" char=".">0.808</td>
              <td style="border:none;" align="char" char=".">0.985</td>
              <td style="border:none;" align="char" char=".">0.834</td>
              <td style="border:none;" align="char" char=".">0.903</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p><xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref> shows that
the five top-ranked ML classifiers on the Main-CV dataset contain
MLP-TPC, SVM-TPC, LR-TPC, SVM-DPC, and SVM-CTD, while the five top-ranked
ML classifiers on the Alter-CV dataset contain MLP-TPC, LR-DPC, SVM-TPC,
SVM-CTD, and SVM-AAC. This demonstrates that MLP-TPC is the most powerful
ML combination for AMAP prediction in terms of both the Main-CV and
Alter-CV datasets. From <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>, iAMAP-SCM is found to yield the third and first highest
MCC of 0.793 and 0.917 for the Main-CV and Alter-CV datasets, respectively.
In the meanwhile, the highest MCC in terms of the Main-CV was found
in MLP-TPC. For the Main-TS and Alter-TS datasets, iAMAP-SCM and MLP-TPC
achieved a similar predictive performance and outperformed the remaining
top-ranked ML classifiers as indicated by BACC and MCC.</p>
      <p>Although
our iAMAP-SCM approach provided a lower AUPR value as
compared with MLP-TPC, SVM-DPC, and SVM-CTD (0.737 versus 0.787–0.794
and 0.869 versus 0.867–0.928 for the Main-TS and Alter-TS datasets,
respectively), the major advantages of iAMAP-SCM over the compared
ML classifiers could be summarized in three aspects: (i) iAMAP-SCM
achieved a competitive performance on the Main-TS and Alter-TS datasets
compared with MLP-TPC. In the meanwhile, iAMAP-SCM outperformed LR,
KNN, and DT classifiers in terms of MCC for the Main-TS and Alter-TS
datasets; (ii) iAMAP-SCM is a simple and easy-to-understand approach
for biologists and biochemists, and (iii) unlike MLP and SVM methods
that are known as black-box computational approaches, iAMAP-SCM is
capable of estimating propensities of 20 amino acids and 400 dipeptides.
This information is beneficial for AMAP characterization.</p>
    </sec>
    <sec id="sec3.4">
      <label>3.4</label>
      <title>Case Studies</title>
      <p>In this section, we
further utilized our iAMAP-SCM approach to perform case studies as
a means to verify its predictive capability in practical situations.
First, we collected experimentally validated AMAPs from various literature
studies.<sup><xref ref-type="bibr" rid="ref57">57</xref>−<xref ref-type="bibr" rid="ref60">60</xref></sup> Second, to alleviate the over-estimation and over-fitting issues,
these AMAPs found in the main and alternative datasets were excluded.
As a result, the remaining 32 AMAPs were obtained and accounted for
the case studies (as listed in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04465/suppl_file/ao2c04465_si_001.pdf">Table S9</ext-link>). As mentioned above, iAMAP-SCM was optimized and constructed by
using the Main-CV and Alter-CV datasets. Therefore, iAMAP-SCM constructed
by these two datasets was performed on the case studies separately.
From <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04465/suppl_file/ao2c04465_si_001.pdf">Tables S10 and S11</ext-link>, several observations
can be made: (i) 20 and 31 samples (ACC of 0.625 and 0.969, respectively)
are correctly identified as AMAPs by iAMAP-SCM developed by using
the Main-CV and Alter-CV datasets, respectively; (ii) MLP-TPC developed
by using the Main-CV and Alter-CV datasets can correctly identify
21 and 24 samples (ACC of 0.656 and 0.750, respectively), respectively;
(iii) Based on the case studies, we noticed that the performance of
the predictive models (i.e., MLP-TPC, SVM-CTD, and iAMAP-SCM) trained
using the Alter-CV dataset is better than that of the predictive models
trained using the Main-CV dataset, demonstrating that the Alter-CV
dataset could be more suitable for creating an efficient predictive
model. In addition, this result indicates that iAMAP-SCM outperformed
the compared methods and could effectively determine candidates as
AMAPs from large-scale proteins.</p>
    </sec>
    <sec id="sec3.5">
      <label>3.5</label>
      <title>Characterization of Antimalarial Peptides
Using SCM-Derived Propensity Scores</title>
      <p>In this section, we employed
SCM-derived amino acid propensities for AMAP characterization. As
mentioned above, the SCM-derived amino acid propensities were generated
using the optimal propensities of 400 dipeptides to be AMAPs (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A) and a straightforward
statistical approach.<sup><xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> As can be seen from <xref rid="tbl6" ref-type="other">Table <xref rid="tbl6" ref-type="other">6</xref></xref>, the top five informative amino acids for AMAPs are Phe,
Ala, Val, His, and Trp. Interestingly, the unique non-polar amino
acids (Phe, Ala, Trp, and Val) and positive charge amino acid (His)
are prevalent in AMAPs as compared to non-AMAPs. Similar to the amino
acid composition results that have been reported before, the preferential
amino acids that are more prominent in AMPs and AMAPs are Ala, Lys,
Arg, Ile, Leu, Phe, Pro, Tyr, and Val.<sup><xref ref-type="bibr" rid="ref31">31</xref>,<xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref61">61</xref>,<xref ref-type="bibr" rid="ref62">62</xref></sup></p>
      <table-wrap id="tbl6" position="float">
        <label>Table 6</label>
        <caption>
          <title>Propensity Scores of 20 Amino Acids
to be AMAPs (PS) along with Different Amino Acid Compositions (%)
of AMAPs and Non-AMAP Based on the Main-CV Dataset</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="char" char="("/>
            <col align="char" char="."/>
            <col align="char" char="."/>
            <col align="char" char="("/>
            <col align="char" char="."/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">amino acid</th>
              <th style="border:none;" align="center" char="(">PS (rank)</th>
              <th style="border:none;" align="center" char=".">AMAP (%)</th>
              <th style="border:none;" align="center" char=".">non-AMAP
(%)</th>
              <th style="border:none;" align="center" char="(">difference
(rank)</th>
              <th style="border:none;" align="center" char="."><italic>p</italic>-value</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">F-Phe</td>
              <td style="border:none;" align="char" char="(">444(1)</td>
              <td style="border:none;" align="char" char=".">10.05</td>
              <td style="border:none;" align="char" char=".">4.81</td>
              <td style="border:none;" align="char" char="(">5.24(1)</td>
              <td style="border:none;" align="char" char=".">0.001</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">A-Ala</td>
              <td style="border:none;" align="char" char="(">419(2)</td>
              <td style="border:none;" align="char" char=".">11.23</td>
              <td style="border:none;" align="char" char=".">7.45</td>
              <td style="border:none;" align="char" char="(">3.78(2)</td>
              <td style="border:none;" align="char" char=".">0.003</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">V-Val</td>
              <td style="border:none;" align="char" char="(">403(3)</td>
              <td style="border:none;" align="char" char=".">8.74</td>
              <td style="border:none;" align="char" char=".">5.71</td>
              <td style="border:none;" align="char" char="(">3.02(3)</td>
              <td style="border:none;" align="char" char=".">0.030</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">H-His</td>
              <td style="border:none;" align="char" char="(">382(4)</td>
              <td style="border:none;" align="char" char=".">3.45</td>
              <td style="border:none;" align="char" char=".">2.21</td>
              <td style="border:none;" align="char" char="(">1.24(7)</td>
              <td style="border:none;" align="char" char=".">0.051</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">W-Trp</td>
              <td style="border:none;" align="char" char="(">372(5)</td>
              <td style="border:none;" align="char" char=".">2.66</td>
              <td style="border:none;" align="char" char=".">1.87</td>
              <td style="border:none;" align="char" char="(">0.80(8)</td>
              <td style="border:none;" align="char" char=".">0.126</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Y-Tyr</td>
              <td style="border:none;" align="char" char="(">371(6)</td>
              <td style="border:none;" align="char" char=".">3.57</td>
              <td style="border:none;" align="char" char=".">2.13</td>
              <td style="border:none;" align="char" char="(">1.44(6)</td>
              <td style="border:none;" align="char" char=".">0.101</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">M-Met</td>
              <td style="border:none;" align="char" char="(">364(7)</td>
              <td style="border:none;" align="char" char=".">1.19</td>
              <td style="border:none;" align="char" char=".">1.26</td>
              <td style="border:none;" align="char" char="(">–0.08(10)</td>
              <td style="border:none;" align="char" char=".">0.846</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">P-Pro</td>
              <td style="border:none;" align="char" char="(">364(8)</td>
              <td style="border:none;" align="char" char=".">4.86</td>
              <td style="border:none;" align="char" char=".">4.71</td>
              <td style="border:none;" align="char" char="(">0.15(9)</td>
              <td style="border:none;" align="char" char=".">0.847</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">K-Lys</td>
              <td style="border:none;" align="char" char="(">359(9)</td>
              <td style="border:none;" align="char" char=".">11.82</td>
              <td style="border:none;" align="char" char=".">10.18</td>
              <td style="border:none;" align="char" char="(">1.65(5)</td>
              <td style="border:none;" align="char" char=".">0.203</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">D-Asp</td>
              <td style="border:none;" align="char" char="(">355(10)</td>
              <td style="border:none;" align="char" char=".">2.16</td>
              <td style="border:none;" align="char" char=".">2.23</td>
              <td style="border:none;" align="char" char="(">–0.08(11)</td>
              <td style="border:none;" align="char" char=".">0.881</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">R-Arg</td>
              <td style="border:none;" align="char" char="(">348(11)</td>
              <td style="border:none;" align="char" char=".">5.90</td>
              <td style="border:none;" align="char" char=".">6.06</td>
              <td style="border:none;" align="char" char="(">–0.16(12)</td>
              <td style="border:none;" align="char" char=".">0.884</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">C-Cys</td>
              <td style="border:none;" align="char" char="(">341(12)</td>
              <td style="border:none;" align="char" char=".">3.62</td>
              <td style="border:none;" align="char" char=".">6.11</td>
              <td style="border:none;" align="char" char="(">–2.49(18)</td>
              <td style="border:none;" align="char" char=".">0.007</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">I-Ile</td>
              <td style="border:none;" align="char" char="(">335(13)</td>
              <td style="border:none;" align="char" char=".">4.64</td>
              <td style="border:none;" align="char" char=".">6.63</td>
              <td style="border:none;" align="char" char="(">–1.99(15)</td>
              <td style="border:none;" align="char" char=".">0.006</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">L-Leu</td>
              <td style="border:none;" align="char" char="(">333(14)</td>
              <td style="border:none;" align="char" char=".">11.73</td>
              <td style="border:none;" align="char" char=".">9.92</td>
              <td style="border:none;" align="char" char="(">1.81(4)</td>
              <td style="border:none;" align="char" char=".">0.178</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">T-Thr</td>
              <td style="border:none;" align="char" char="(">320(15)</td>
              <td style="border:none;" align="char" char=".">1.75</td>
              <td style="border:none;" align="char" char=".">4.19</td>
              <td style="border:none;" align="char" char="(">–2.44(17)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">E-Glu</td>
              <td style="border:none;" align="char" char="(">318(16)</td>
              <td style="border:none;" align="char" char=".">0.84</td>
              <td style="border:none;" align="char" char=".">2.20</td>
              <td style="border:none;" align="char" char="(">–1.36(14)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">N-Asn</td>
              <td style="border:none;" align="char" char="(">318(17)</td>
              <td style="border:none;" align="char" char=".">1.54</td>
              <td style="border:none;" align="char" char=".">3.53</td>
              <td style="border:none;" align="char" char="(">–1.99(16)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">G-Gly</td>
              <td style="border:none;" align="char" char="(">312(18)</td>
              <td style="border:none;" align="char" char=".">7.10</td>
              <td style="border:none;" align="char" char=".">10.62</td>
              <td style="border:none;" align="char" char="(">–3.52(19)</td>
              <td style="border:none;" align="char" char=".">0.009</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">Q-Gln</td>
              <td style="border:none;" align="char" char="(">308(19)</td>
              <td style="border:none;" align="char" char=".">1.80</td>
              <td style="border:none;" align="char" char=".">2.23</td>
              <td style="border:none;" align="char" char="(">–0.44(13)</td>
              <td style="border:none;" align="char" char=".">0.343</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">S-Ser</td>
              <td style="border:none;" align="char" char="(">275(20)</td>
              <td style="border:none;" align="char" char=".">1.34</td>
              <td style="border:none;" align="char" char=".">5.94</td>
              <td style="border:none;" align="char" char="(">–4.60(20)</td>
              <td style="border:none;" align="char" char=".">0.000</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>For the amphipathic feature of AMPs, peptide interactions
with
the membranes are driven by both the hydrophilic and lipophilic nature
of the peptides. The positive charge or cationic side chain amino
acids (Arg, Lys, and His) and bulky (Pro, Phe, Val, Ile and Trp) side
chains are fundamental for peptide antimicrobial activity.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> This is also correlated to several pieces of
evidence that have reported that the amino acids Ala, Lys, Arg, Ile,
Leu, Phe, Pro, Tyr, and Val are frequently included on antimicrobial
and antimalarial peptides. In the case of the hydrophobic character
of AMPs, Val, Phe, and Pro are considered to be important for collapsing
the plasmodium cell membrane.<sup><xref ref-type="bibr" rid="ref62">62</xref>,<xref ref-type="bibr" rid="ref64">64</xref>−<xref ref-type="bibr" rid="ref66">66</xref></sup> Research observed that deletion of Val could lead to a 23% decrease
in the antiplasmodial activity.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> Since
Phe is necessary for proficient antibacterial activity and membrane
phospholipid interaction,<sup><xref ref-type="bibr" rid="ref66">66</xref></sup> the substitution
of polar residues (Arg or Lys) by Phe could promisingly increase antimalarial
activity.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> Furthermore, a study observed
the parasite specific property of Phe in combination with Pro to show
lower toxicity toward healthy cells such as erythrocytes and fibroblasts.<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> For the positively charged amino acids with
the fourth highest propensity score (His), it was observed that His-rich
amphipathic cationic peptides could significantly enhance membrane
disruption and antimicrobial activities including their antimalarial
ability.<sup><xref ref-type="bibr" rid="ref68">68</xref></sup></p>
    </sec>
    <sec id="sec3.6">
      <label>3.6</label>
      <title>Characterization of Antimalarial Peptides
Using Informative Physicochemical Properties</title>
      <p>In this section,
iAMAP-SCM coupled with the SCM-derived amino acid propensities was
applied to select informative PCPs for AMAP characterization. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04465/suppl_file/ao2c04465_si_001.pdf">Table S6</ext-link> lists the top 20 PCPs with the highest <italic>R</italic>-values, which are perceived as most important for AMAP
characterization. As seen in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04465/suppl_file/ao2c04465_si_001.pdf">Table S6</ext-link>,
the top five PCPs with the highest <italic>R</italic>-values consisted
of TAKK010101, BIOV880101, RICJ880111, BIOV880102, and CIDH920102,
respectively. Detailed analysis results of these important PCPs for
AMAPs are provided in the following subsections.</p>
      <sec id="sec3.6.1">
        <label>3.6.1</label>
        <title>AMAPs Have High Conformational and Thermal
Stability</title>
        <p>The TAKK010101 can be described as “side-chain
contribution to protein stability (kJ/mol)”.<sup><xref ref-type="bibr" rid="ref69">69</xref></sup> The stability estimation profile is a powerful tool that
has shown to be useful in the analysis of protein sequences. Since
the side-chain contribution to protein stability includes the entropic
effect, they might represent the contributions of each amino acid
side chain to the conformational stability of the globular protein.
However, the high <italic>R</italic>-value implies that hydrophobic
amino acids contribute largely to AMAPs. Notably, the five top-ranked
amino acids were Trp, Phe, Ile, Tyr, and Leu, possessing the highest
side chain hydrophobicity values.<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> As
previously mentioned above, from the amino acid propensity results,
the overall stability of AMAPs is high, with the five top-ranked amino
acids being highly hydrophobic (non-polar) side chains. Research has
suggested that Trp and Phe are involved in peptide structural stability
by restricting their conformation through hydrogen bond formation,
affecting the antiplasmodial activity.<sup><xref ref-type="bibr" rid="ref71">71</xref></sup> In addition, it has been reported that non-polar aliphatic amino
acids (Ala, Ile, Leu, and Val) are responsible for the thermal stability
of proteins and peptides.<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> These non-polar
amino acid compositions indicate that AMAPs tend to be highly thermostable
and conformationally stable in general. Thus, certain features such
as high activity and thermostability coupled with peptide shelf life
and stability in the host have made AMAPs an attractive endeavor for
peptide drug discovery applications against malaria.</p>
      </sec>
      <sec id="sec3.6.2">
        <label>3.6.2</label>
        <title>AMAPs Are Composed of Hydrophobic Amino
Acids</title>
        <p>The CIDH920102 property was found at rank five, which
is described as normalized hydrophobicity scales for beta-proteins.<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> Thus, it could be implied that side-chain hydrophobicity
might be important to AMAPs. <xref rid="tbl7" ref-type="other">Table <xref rid="tbl7" ref-type="other">7</xref></xref> indicates the informative amino acids of the top five
AMAPs (i.e., Phe, Ala, Val, His, and Trp) ranked by the propensity
scores. In the meanwhile, the residues having the highest scores for
the CIDH920102 property were Trp, Phe, Tyr, Ile, and Met.<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> The hydrophobicity of the nonpolar side of amphipathic
helical peptides is correlated with peptide helicity and their ability
to self-associate in aqueous environments, which is involved in peptide
stability and membrane–peptide interaction.<sup><xref ref-type="bibr" rid="ref72">72</xref>,<xref ref-type="bibr" rid="ref74">74</xref></sup> An abundance of hydrophobic amino acids is significant in AMPs both
of non-polar aliphatic and aromatic side chains.<sup><xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref76">76</xref></sup> Since a significantly high hydrophobic activity in AMPs can cause
a strong hemolytic activity on erythrocytes,<sup><xref ref-type="bibr" rid="ref74">74</xref></sup> an optimum hydrophobicity value is necessary to obtain both maximum
specificity and activity of AMAPs.</p>
        <table-wrap id="tbl7" position="float">
          <label>Table 7</label>
          <caption>
            <title>Five Important Physicochemical Properties
(PCPs) Derived from iAMAP-SCM<xref rid="t7fn1" ref-type="table-fn">a</xref></title>
          </caption>
          <table frame="hsides" rules="groups" border="0">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead>
              <tr>
                <th style="border:none;" align="center">amino acid</th>
                <th style="border:none;" align="center">PS (rank)</th>
                <th style="border:none;" align="center">PCP1 (rank)</th>
                <th style="border:none;" align="center">PCP2 (rank)</th>
                <th style="border:none;" align="center">PCP3 (rank)</th>
                <th style="border:none;" align="center">PCP4 (rank)</th>
                <th style="border:none;" align="center">PCP5 (rank)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td style="border:none;" align="left">F-Phe</td>
                <td style="border:none;" align="left">444(1)</td>
                <td style="border:none;" align="left">444(1)</td>
                <td style="border:none;" align="left">23.0(2)</td>
                <td style="border:none;" align="left">189(1)</td>
                <td style="border:none;" align="left">2.9(1)</td>
                <td style="border:none;" align="left">148(1)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">A-Ala</td>
                <td style="border:none;" align="left">419(2)</td>
                <td style="border:none;" align="left">419(2)</td>
                <td style="border:none;" align="left">9.8(11)</td>
                <td style="border:none;" align="left">16(10)</td>
                <td style="border:none;" align="left">1.3(8)</td>
                <td style="border:none;" align="left">44(8)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">V-Val</td>
                <td style="border:none;" align="left">403(3)</td>
                <td style="border:none;" align="left">403(3)</td>
                <td style="border:none;" align="left">15.3(6)</td>
                <td style="border:none;" align="left">123(7)</td>
                <td style="border:none;" align="left">1.4(7)</td>
                <td style="border:none;" align="left">117(7)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">H-His</td>
                <td style="border:none;" align="left">382(4)</td>
                <td style="border:none;" align="left">382(4)</td>
                <td style="border:none;" align="left">11.9(8)</td>
                <td style="border:none;" align="left">50(9)</td>
                <td style="border:none;" align="left">1.9(4)</td>
                <td style="border:none;" align="left">47(4)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">W-Trp</td>
                <td style="border:none;" align="left">372(5)</td>
                <td style="border:none;" align="left">372(5)</td>
                <td style="border:none;" align="left">24.2(1)</td>
                <td style="border:none;" align="left">145(4)</td>
                <td style="border:none;" align="left">2.1(3)</td>
                <td style="border:none;" align="left">163(3)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Y-Tyr</td>
                <td style="border:none;" align="left">371(6)</td>
                <td style="border:none;" align="left">371(6)</td>
                <td style="border:none;" align="left">17.2(4)</td>
                <td style="border:none;" align="left">53(8)</td>
                <td style="border:none;" align="left">0.8(10)</td>
                <td style="border:none;" align="left">22(10)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">M-Met</td>
                <td style="border:none;" align="left">364(7)</td>
                <td style="border:none;" align="left">364(7)</td>
                <td style="border:none;" align="left">11.9(9)</td>
                <td style="border:none;" align="left">124(6)</td>
                <td style="border:none;" align="left">2.8(2)</td>
                <td style="border:none;" align="left">121(2)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">P-Pro</td>
                <td style="border:none;" align="left">364(8)</td>
                <td style="border:none;" align="left">364(8)</td>
                <td style="border:none;" align="left">15.0(7)</td>
                <td style="border:none;" align="left">–20(12)</td>
                <td style="border:none;" align="left">0.0(20)</td>
                <td style="border:none;" align="left">–36(20)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">K-Lys</td>
                <td style="border:none;" align="left">359(9)</td>
                <td style="border:none;" align="left">359(9)</td>
                <td style="border:none;" align="left">10.5(10)</td>
                <td style="border:none;" align="left">–141(20)</td>
                <td style="border:none;" align="left">1.0(9)</td>
                <td style="border:none;" align="left">–188(9)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">D-Asp</td>
                <td style="border:none;" align="left">355(10)</td>
                <td style="border:none;" align="left">355(10)</td>
                <td style="border:none;" align="left">4.9(14)</td>
                <td style="border:none;" align="left">–78(18)</td>
                <td style="border:none;" align="left">0.5(18)</td>
                <td style="border:none;" align="left">–91(18)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">R-Arg</td>
                <td style="border:none;" align="left">348(11)</td>
                <td style="border:none;" align="left">348(11)</td>
                <td style="border:none;" align="left">7.3(12)</td>
                <td style="border:none;" align="left">–70(14)</td>
                <td style="border:none;" align="left">0.8(11)</td>
                <td style="border:none;" align="left">–68(11)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">C-Cys</td>
                <td style="border:none;" align="left">341(12)</td>
                <td style="border:none;" align="left">341(12)</td>
                <td style="border:none;" align="left">3.0(17)</td>
                <td style="border:none;" align="left">168(2)</td>
                <td style="border:none;" align="left">0.7(12)</td>
                <td style="border:none;" align="left">90(12)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">I-Ile</td>
                <td style="border:none;" align="left">335(13)</td>
                <td style="border:none;" align="left">335(13)</td>
                <td style="border:none;" align="left">17.2(3)</td>
                <td style="border:none;" align="left">151(3)</td>
                <td style="border:none;" align="left">1.6(5)</td>
                <td style="border:none;" align="left">100(5)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">L-Leu</td>
                <td style="border:none;" align="left">333(14)</td>
                <td style="border:none;" align="left">333(14)</td>
                <td style="border:none;" align="left">17.0(5)</td>
                <td style="border:none;" align="left">145(5)</td>
                <td style="border:none;" align="left">1.4(6)</td>
                <td style="border:none;" align="left">108(6)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">T-Thr</td>
                <td style="border:none;" align="left">320(15)</td>
                <td style="border:none;" align="left">320(15)</td>
                <td style="border:none;" align="left">6.9(13)</td>
                <td style="border:none;" align="left">–38(13)</td>
                <td style="border:none;" align="left">0.6(14)</td>
                <td style="border:none;" align="left">–54(14)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">E-Glu</td>
                <td style="border:none;" align="left">318(16)</td>
                <td style="border:none;" align="left">318(16)</td>
                <td style="border:none;" align="left">4.4(15)</td>
                <td style="border:none;" align="left">–106(19)</td>
                <td style="border:none;" align="left">0.7(13)</td>
                <td style="border:none;" align="left">–139(13)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">N-Asn</td>
                <td style="border:none;" align="left">318(17)</td>
                <td style="border:none;" align="left">318(17)</td>
                <td style="border:none;" align="left">3.6(16)</td>
                <td style="border:none;" align="left">–74(17)</td>
                <td style="border:none;" align="left">0.6(15)</td>
                <td style="border:none;" align="left">–72(15)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">G-Gly</td>
                <td style="border:none;" align="left">312(18)</td>
                <td style="border:none;" align="left">312(18)</td>
                <td style="border:none;" align="left">0.0(20)</td>
                <td style="border:none;" align="left">–13(11)</td>
                <td style="border:none;" align="left">0.5(16)</td>
                <td style="border:none;" align="left">–8(16)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">Q-Gln</td>
                <td style="border:none;" align="left">308(19)</td>
                <td style="border:none;" align="left">308(19)</td>
                <td style="border:none;" align="left">2.4(19)</td>
                <td style="border:none;" align="left">–73(16)</td>
                <td style="border:none;" align="left">0.2(19)</td>
                <td style="border:none;" align="left">–117(19)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">S-Ser</td>
                <td style="border:none;" align="left">275(20)</td>
                <td style="border:none;" align="left">275(20)</td>
                <td style="border:none;" align="left">2.6(18)</td>
                <td style="border:none;" align="left">–70(15)</td>
                <td style="border:none;" align="left">0.5(17)</td>
                <td style="border:none;" align="left">–60(17)</td>
              </tr>
              <tr>
                <td style="border:none;" align="left">
                  <italic>R</italic>
                </td>
                <td style="border:none;" align="left">1.000</td>
                <td style="border:none;" align="left">0.666</td>
                <td style="border:none;" align="left">0.629</td>
                <td style="border:none;" align="left">0.621</td>
                <td style="border:none;" align="left">0.615</td>
                <td style="border:none;" align="left">0.564</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="t7fn1">
              <label>a</label>
              <p>PCP1 = TAKK010101 (side-chain contribution
to protein stability (kJ/mol) (Takano–Yutani, 2001)); PCP2
= BIOV880101 (information value for accessibility; average fraction
35% (Biou et al., 1988)); PCP3 = RICJ880111 (relative preference value
at C4 (Richardson–Richardson, 1988)); PCP4 = BIOV880102 (information
value for accessibility; average fraction 23% (Biou et al., 1988));
PCP5 = CIDH92010 (normalized hydrophobicity scales for beta-proteins
(Cid et al., 1992)).</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="sec3.6.3">
        <label>3.6.3</label>
        <title>AMAPs Are Composed of Amino Acids Interacting
with Cell Membranes</title>
        <p>To group amino acids based on peptide
solubility, we analyzed the protein/peptide solubility based on the
Amino Acid Index Database.<sup><xref ref-type="bibr" rid="ref77">77</xref></sup> Relevant to
the solvent accessibility property, the PCPs common to both the hydrophilic
and hydrophobic residues, the BIOV880101 and BIOV880102 properties,
are described as “Information value for accessibility; average
fraction 35%” and “Information value for accessibility;
average fraction 23%”,<sup><xref ref-type="bibr" rid="ref78">78</xref></sup> respectively.
The high correlation between the 20 amino acid propensities and these
two PCPs highlight that high membrane propensity is a key component
of amino acids for AMAPs. Notably, the top seven amino acids with
the highest propensity scores in the BIOV880101 and BIOV880102 properties
(Phe, Cys, Ile, Trp, Leu, Met, and Val) are all non-polar side-chain
amino acids.<sup><xref ref-type="bibr" rid="ref78">78</xref></sup> These hydrophobic residues
in the amphipathic AMPs affect membrane permeabilization via pore
formation that is more sensitive to phospholipid bilayers with a negative
charge.<sup><xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref80">80</xref></sup> This high positive correlation strongly
indicates that AMAPs favor non-polar aliphatic and aromatic amino
acids, which play an important role in peptide–membrane interactions.<sup><xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref82">82</xref></sup></p>
      </sec>
      <sec id="sec3.6.4">
        <label>3.6.4</label>
        <title>AMAPs Tend to be in the Amphipathic Antimicrobial
Peptide Class</title>
        <p>The property of RICJ880111, described as “relative
preference value at C4”,<sup><xref ref-type="bibr" rid="ref83">83</xref></sup> was found
at rank 3. As a result, the high positive correlation of the RICJ880111
property and the top eight informative amino acids (i.e., Phe, Met,
Trp, Ile, Leu, Val, Ala, and His) indicate that AMAPs favor hydrophobic
amino acids and tend to be in the amphipathic AMP class. The interface
residue of globular protein structures, characterized by a half-in/half-out
phenomenon, is termed N-cap or C-cap. This is based on the fact that
the hydrophobic residues are highly conserved on α-carbon positions
4 of C-cap (C4).<sup><xref ref-type="bibr" rid="ref83">83</xref></sup> The amphiphilic property
enhances cellular membrane permeability through ion channel formation
and thus disrupts the lipid bilayer.<sup><xref ref-type="bibr" rid="ref84">84</xref>,<xref ref-type="bibr" rid="ref85">85</xref></sup> In general,
peptides acting on membranes exhibit their amphipathic activity in
secondary structure form once they are in a membrane environment.<sup><xref ref-type="bibr" rid="ref85">85</xref></sup> Owing to the potent clinical relevance of membrane
active peptides, the correlation of AMP structure–function
relationship has been extensively investigated.<sup><xref ref-type="bibr" rid="ref85">85</xref>−<xref ref-type="bibr" rid="ref88">88</xref></sup> The formation of amphipathic
conformations can be observed when the cationic amphipathic peptides
are located in membrane environments.<sup><xref ref-type="bibr" rid="ref89">89</xref>−<xref ref-type="bibr" rid="ref91">91</xref></sup> Notably, other conformations
can also result in an amphipathic separation of hydrophobic and polar
residues, efficient membrane interactions, and antimicrobial activities.<sup><xref ref-type="bibr" rid="ref90">90</xref>,<xref ref-type="bibr" rid="ref91">91</xref></sup> The amphipathic separation of hydrophobic and polar residues illustrates
the specific interactions of AMPs with the phospholipid membrane interfaces.<sup><xref ref-type="bibr" rid="ref89">89</xref></sup></p>
      </sec>
    </sec>
  </sec>
  <sec id="sec4">
    <label>4</label>
    <title>Conclusions</title>
    <p>In this study, we have
developed iAMAP-SCM, an interpretable and
efficient ML-based predictor for the high-throughput identification
and characterization of peptides with antimalarial activity using
only sequence information. To the best of our knowledge, iAMAP-SCM
is the first ML-based approach designed for AMAP identification and
characterization. To be specific, this new predictor was developed
based on the interpretable SCM method and estimated propensities of
20 amino acids and 400 dipeptides to be AMAPs. Experimental results
based on the training and independent test datasets revealed that
iAMAP-SCM achieved a competitive performance in AMAP prediction and
outperformed several ML-based predictors in terms of simplicity and
interpretability. Additionally, the iAMAP-SCM-derived analysis results
demonstrated four important characteristics of AMAPs, which can be
encapsulated as follows: (i) AMAPs have high conformational and thermal
stability; (ii) AMAPs are composed of hydrophobic amino acids; (iii)
AMAPs are composed of amino acids interacting with cell membranes;
and (iv) AMAPs tend to be in the amphipathic antimicrobial peptide
class. Finally, a user-friendly online computational platform of iAMAP-SCM
is publicly available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pmlabstack.pythonanywhere.com/iAMAP-SCM">http://pmlabstack.pythonanywhere.com/iAMAP-SCM</uri>.</p>
  </sec>
</body>
<back>
  <notes id="notes2" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting
Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acsomega.2c04465?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsomega.2c04465</ext-link>.<list id="silist" list-type="simple"><list-item><p>Performance evaluations of iAMAP-SCM and several ML-based
classifiers; training and independent test datasets; peptide length
distribution of AMAPs and non-AMAPs; hyperparameter search details;
cross-validation results; independent test results; detailed information
of the external dataset; detailed prediction results; and 20 top-ranked
informative PCPs (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.2c04465/suppl_file/ao2c04465_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao2c04465_si_001.pdf">
        <caption>
          <p>ao2c04465_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="COI-statement" id="NOTES-d14e3860-autogenerated">
    <p>The
authors declare no
competing financial interest.</p>
  </notes>
  <notes notes-type="" id="notes1">
    <title>Notes</title>
    <p>All
the data used in this study are available
at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pmlabstack.pythonanywhere.com/iAMAP-SCM">http://pmlabstack.pythonanywhere.com/iAMAP-SCM</uri>.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>This work was fully supported by College of Arts,
Media and Technology, Chiang Mai University, and partially supported
by Chiang Mai University and Mahidol University. In addition, computational
resources were supported by Information Technology Service Center
(ITSC) of Chiang Mai University.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Ghosh</surname><given-names>A. K.</given-names></name>; <name><surname>Ribolla</surname><given-names>P. E.</given-names></name>; <name><surname>Jacobs-Lorena</surname><given-names>M.</given-names></name><article-title>Targeting Plasmodium ligands on mosquito
salivary glands and midgut with a phage display peptide library</article-title>. <source>Proc. Natl. Acad. Sci.</source><year>2001</year>, <volume>98</volume>, <fpage>13278</fpage>–<lpage>13281</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.241491198</pub-id>.<pub-id pub-id-type="pmid">11687659</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Gao</surname><given-names>B.</given-names></name>; <name><surname>Xu</surname><given-names>J.</given-names></name>; <name><surname>del Carmen Rodriguez</surname><given-names>M.</given-names></name>; <name><surname>Lanz-Mendoza</surname><given-names>H.</given-names></name>; <name><surname>Hernández-Rivas</surname><given-names>R.</given-names></name>; <name><surname>Du</surname><given-names>W.</given-names></name>; <name><surname>Zhu</surname><given-names>S.</given-names></name><article-title>Characterization
of two linear cationic antimalarial peptides in the scorpion Mesobuthus
eupeus</article-title>. <source>Biochimie</source><year>2010</year>, <volume>92</volume>, <fpage>350</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1016/j.biochi.2010.01.011</pub-id>.<pub-id pub-id-type="pmid">20097251</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Bell</surname><given-names>A.</given-names></name><article-title>Antimalarial
peptides: the long and the short of it</article-title>. <source>Curr.
Pharm. Des.</source><year>2011</year>, <volume>17</volume>, <fpage>2719</fpage>–<lpage>2731</lpage>. <pub-id pub-id-type="doi">10.2174/138161211797416057</pub-id>.<pub-id pub-id-type="pmid">21728986</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Hancock</surname><given-names>R. E. W.</given-names></name>; <name><surname>Sahl</surname><given-names>H.-G.</given-names></name><article-title>Antimicrobial and
host-defense peptides as new anti-infective
therapeutic strategies</article-title>. <source>Nat. Biotechnol.</source><year>2006</year>, <volume>24</volume>, <fpage>1551</fpage>–<lpage>1557</lpage>. <pub-id pub-id-type="doi">10.1038/nbt1267</pub-id>.<pub-id pub-id-type="pmid">17160061</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Mor</surname><given-names>A.</given-names></name><article-title>Multifunctional
host defense peptides: antiparasitic activities</article-title>. <source>FEBS J.</source><year>2009</year>, <volume>276</volume>, <fpage>6474</fpage>–<lpage>6482</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07358.x</pub-id>.<pub-id pub-id-type="pmid">19817857</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Splith</surname><given-names>K.</given-names></name>; <name><surname>Neundorf</surname><given-names>I.</given-names></name><article-title>Antimicrobial peptides
with cell-penetrating peptide
properties and vice versa</article-title>. <source>Eur. Biophys. J.</source><year>2011</year>, <volume>40</volume>, <fpage>387</fpage>–<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1007/s00249-011-0682-7</pub-id>.<pub-id pub-id-type="pmid">21336522</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Vizioli</surname><given-names>J.</given-names></name>; <name><surname>Bulet</surname><given-names>P.</given-names></name>; <name><surname>Hoffmann</surname><given-names>J. A.</given-names></name>; <name><surname>Kafatos</surname><given-names>F. C.</given-names></name>; <name><surname>Müller</surname><given-names>H.-M.</given-names></name>; <name><surname>Dimopoulos</surname><given-names>G.</given-names></name><article-title>Gambicin:
a novel immune responsive antimicrobial peptide
from the malaria vector Anopheles gambiae</article-title>. <source>Proc.
Natl. Acad. Sci.</source><year>2001</year>, <volume>98</volume>, <fpage>12630</fpage>–<lpage>12635</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.221466798</pub-id>.<pub-id pub-id-type="pmid">11606751</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Shahabuddin</surname><given-names>M.</given-names></name>; <name><surname>Fields</surname><given-names>I.</given-names></name>; <name><surname>Bulet</surname><given-names>P.</given-names></name>; <name><surname>Hoffmann</surname><given-names>J. A.</given-names></name>; <name><surname>Miller</surname><given-names>L. H.</given-names></name><article-title>Plasmodium
gallinaceum: differential killing of some mosquito stages of the parasite
by insect defensin</article-title>. <source>Exp. Parasitol.</source><year>1998</year>, <volume>89</volume>, <fpage>103</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1006/expr.1998.4212</pub-id>.<pub-id pub-id-type="pmid">9603495</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Boman</surname><given-names>H. G.</given-names></name>; <name><surname>Wade</surname><given-names>D.</given-names></name>; <name><surname>Boman</surname><given-names>I. A.</given-names></name>; <name><surname>Wåhlin</surname><given-names>B.</given-names></name>; <name><surname>Merrifield</surname><given-names>R. B.</given-names></name><article-title>Antibacterial and antimalarial properties of peptides
that are cecropin-melittin hybrids</article-title>. <source>FEBS Lett.</source><year>1989</year>, <volume>259</volume>, <fpage>103</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(89)81505-4</pub-id>.<pub-id pub-id-type="pmid">2689223</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Jaynes</surname><given-names>J. M.</given-names></name>; <name><surname>Burton</surname><given-names>C. A.</given-names></name>; <name><surname>Barr</surname><given-names>S. B.</given-names></name>; <name><surname>Jeffers</surname><given-names>G. W.</given-names></name>; <name><surname>Julian</surname><given-names>G. R.</given-names></name>; <name><surname>White</surname><given-names>K. L.</given-names></name>; <name><surname>Enright</surname><given-names>F. M.</given-names></name>; <name><surname>Klei</surname><given-names>T. R.</given-names></name>; <name><surname>Laine</surname><given-names>R. A.</given-names></name><article-title>In vitro
cytocidal effect of novel lytic peptides on Plasmodium falciparum
and Trypanosoma cruzi 1</article-title>. <source>FASEB J.</source><year>1988</year>, <volume>2</volume>, <fpage>2878</fpage>–<lpage>2883</lpage>. <pub-id pub-id-type="doi">10.1096/fasebj.2.13.3049204</pub-id>.<pub-id pub-id-type="pmid">3049204</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Gwadz</surname><given-names>R. W.</given-names></name>; <name><surname>Kaslow</surname><given-names>D.</given-names></name>; <name><surname>Lee</surname><given-names>J.-Y.</given-names></name>; <name><surname>Maloy</surname><given-names>W. L.</given-names></name>; <name><surname>Zasloff</surname><given-names>M.</given-names></name>; <name><surname>Miller</surname><given-names>L. H.</given-names></name><article-title>Effects of magainins
and cecropins on the sporogonic
development of malaria parasites in mosquitoes</article-title>. <source>Infect. Immun.</source><year>1989</year>, <volume>57</volume>, <fpage>2628</fpage>–<lpage>2633</lpage>. <pub-id pub-id-type="doi">10.1128/iai.57.9.2628-2633.1989</pub-id>.<pub-id pub-id-type="pmid">2759705</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>van den Eertwegh</surname><given-names>V.</given-names></name>; <name><surname>Tournois</surname><given-names>H.</given-names></name>; <name><surname>Roelofsen</surname><given-names>B.</given-names></name>; <name><surname>den Kamp</surname><given-names>J. A. O.</given-names></name>; <name><surname>van
Deenen</surname><given-names>L. L.</given-names></name><article-title>Growth inhibition of Plasmodium falciparum
in in vitro cultures by selective action of tryptophan-N-formylated
gramicidin incorporated in lipid vesicles</article-title>. <source>Biochim.
Biophys. Acta, Biomembr.</source><year>1991</year>, <volume>1062</volume>, <fpage>206</fpage>–<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1016/0005-2736(91)90394-N</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Otten-Kuipers</surname><given-names>M. A.</given-names></name>; <name><surname>Roelofsen</surname><given-names>B.</given-names></name>; <name><surname>Op den Kamp</surname><given-names>J. A.</given-names></name><article-title>Stage-dependent effects of analogs
of gramicidin A on the growth ofPlasmodium falciparum in vitro</article-title>. <source>Parasitol. Res.</source><year>1995</year>, <volume>81</volume>, <fpage>26</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1007/BF00932413</pub-id>.<pub-id pub-id-type="pmid">7536920</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Gumila</surname><given-names>C.</given-names></name>; <name><surname>Ancelin</surname><given-names>M.-L.</given-names></name>; <name><surname>Delort</surname><given-names>A.-M.</given-names></name>; <name><surname>Jeminet</surname><given-names>G.</given-names></name>; <name><surname>Vial</surname><given-names>H. J.</given-names></name><article-title>Characterization
of the potent in vitro and in vivo antimalarial activities of ionophore
compounds</article-title>. <source>Antimicrob. Agents Chemother.</source><year>1997</year>, <volume>41</volume>, <fpage>523</fpage>–<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.41.3.523</pub-id>.<pub-id pub-id-type="pmid">9055986</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>McColm</surname><given-names>A. A.</given-names></name>; <name><surname>McHardy</surname><given-names>N.</given-names></name><article-title>Evaluation of a range of antimicrobial
agents against
the parasitic protozoa, Plasmodium falciparum, Babesia rodhaini and
Theileria parva in vitro</article-title>. <source>Ann. Trop. Med. Parasitol.</source><year>1984</year>, <volume>78</volume>, <fpage>345</fpage>–<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1080/00034983.1984.11811831</pub-id>.<pub-id pub-id-type="pmid">6206808</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Bell</surname><given-names>A.</given-names></name>; <name><surname>Roberts</surname><given-names>H. C.</given-names></name>; <name><surname>Chappell</surname><given-names>L. H.</given-names></name><article-title>The antiparasite
effects of cyclosporin
A: possible drug targets and clinical applications</article-title>. <source>Gen. Pharmacol.</source><year>1996</year>, <volume>27</volume>, <fpage>963</fpage>–<lpage>971</lpage>. <pub-id pub-id-type="doi">10.1016/0306-3623(95)02148-5</pub-id>.<pub-id pub-id-type="pmid">8909976</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Aminake</surname><given-names>M. N.</given-names></name>; <name><surname>Schoof</surname><given-names>S.</given-names></name>; <name><surname>Sologub</surname><given-names>L.</given-names></name>; <name><surname>Leubner</surname><given-names>M.</given-names></name>; <name><surname>Kirschner</surname><given-names>M.</given-names></name>; <name><surname>Arndt</surname><given-names>H.-D.</given-names></name>; <name><surname>Pradel</surname><given-names>G.</given-names></name><article-title>Thiostrepton
and derivatives exhibit
antimalarial and gametocytocidal activity by dually targeting parasite
proteasome and apicoplast</article-title>. <source>Antimicrob. Agents
Chemother.</source><year>2011</year>, <volume>55</volume>, <fpage>1338</fpage>–<lpage>1348</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01096-10</pub-id>.<pub-id pub-id-type="pmid">21245445</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Clough</surname><given-names>B.</given-names></name>; <name><surname>Rangachari</surname><given-names>K.</given-names></name>; <name><surname>Strath</surname><given-names>M.</given-names></name>; <name><surname>Preiser</surname><given-names>P. R.</given-names></name>; <name><surname>Wilson</surname><given-names>R. I.</given-names></name><article-title>Antibiotic
inhibitors of organellar protein synthesis in Plasmodium falciparum</article-title>. <source>Protist</source><year>1999</year>, <volume>150</volume>, <fpage>189</fpage>–<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/S1434-4610(99)70021-0</pub-id>.<pub-id pub-id-type="pmid">10505418</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Sullivan</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Kumar</surname><given-names>S.</given-names></name>; <name><surname>Rogers</surname><given-names>M. J.</given-names></name>; <name><surname>McCutchan</surname><given-names>T. F.</given-names></name><article-title>Effects
of interruption of apicoplast function on malaria infection, development,
and transmission</article-title>. <source>Mol. Biochem. Parasitol.</source><year>2000</year>, <volume>109</volume>, <fpage>17</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-6851(00)00226-7</pub-id>.<pub-id pub-id-type="pmid">10924753</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Boman</surname><given-names>H.</given-names></name><article-title>Antibacterial
peptides: basic facts and emerging concepts</article-title>. <source>J. Int. Med.</source><year>2003</year>, <volume>254</volume>, <fpage>197</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2796.2003.01228.x</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Nagaraj</surname><given-names>G.</given-names></name>; <name><surname>Uma</surname><given-names>M. V.</given-names></name>; <name><surname>Shivayogi</surname><given-names>M. S.</given-names></name>; <name><surname>Balaram</surname><given-names>H.</given-names></name><article-title>Antimalarial activities
of peptide antibiotics isolated from fungi</article-title>. <source>Antimicrob. Agents Chemother.</source><year>2001</year>, <volume>45</volume>, <fpage>145</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.45.1.145-149.2001</pub-id>.<pub-id pub-id-type="pmid">11120957</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Aronimo</surname><given-names>B. S.</given-names></name>; <name><surname>Okoro</surname><given-names>U. C.</given-names></name>; <name><surname>Ali</surname><given-names>R.</given-names></name>; <name><surname>Ibeji</surname><given-names>C. U.</given-names></name>; <name><surname>Ezugwu</surname><given-names>J. A.</given-names></name>; <name><surname>Ugwu</surname><given-names>D. I.</given-names></name><article-title>Synthesis, molecular
docking and antimalarial activity
of phenylalanine-glycine dipeptide bearing sulphonamide moiety</article-title>. <source>J. Mol. Struct.</source><year>2021</year>, <volume>1246</volume>, <elocation-id>131201</elocation-id><pub-id pub-id-type="doi">10.1016/j.molstruc.2021.131201</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Ekoh</surname><given-names>O. C.</given-names></name>; <name><surname>Okoro</surname><given-names>U.</given-names></name>; <name><surname>Ugwu</surname><given-names>D.</given-names></name>; <name><surname>Ali</surname><given-names>R.</given-names></name>; <name><surname>Okafor</surname><given-names>S.</given-names></name>; <name><surname>Ugwuja</surname><given-names>D.</given-names></name>; <name><surname>Attah</surname><given-names>S.</given-names></name><article-title>Novel Dipeptides Bearing
Sulfonamide
as Antimalarial and Antitrypanosomal Agents: Synthesis and Molecular
Docking</article-title>. <source>Med. Chem.</source><year>2022</year>, <volume>18</volume>, <fpage>394</fpage>–<lpage>405</lpage>. <pub-id pub-id-type="doi">10.2174/1573406417666210604101201</pub-id>.<pub-id pub-id-type="pmid">34097595</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Ezugwu</surname><given-names>J. A.</given-names></name>; <name><surname>Okoro</surname><given-names>U. C.</given-names></name>; <name><surname>Ezeokonkwo</surname><given-names>M. A.</given-names></name>; <name><surname>Hariprasad</surname><given-names>K. S.</given-names></name>; <name><surname>Rudrapal</surname><given-names>M.</given-names></name>; <name><surname>Ugwu</surname><given-names>D. I.</given-names></name>; <name><surname>Gogoi</surname><given-names>N.</given-names></name>; <name><surname>Chetia</surname><given-names>D.</given-names></name>; <name><surname>Celik</surname><given-names>I.</given-names></name>; <name><surname>Ekoh</surname><given-names>O. C.</given-names></name><article-title>Design, Synthesis,
Molecular Docking,
Molecular Dynamics and In Vivo Antimalarial Activity of New Dipeptide-Sulfonamides</article-title>. <source>ChemistrySelect</source><year>2022</year>, <volume>7</volume>, <elocation-id>e202103908</elocation-id><pub-id pub-id-type="doi">10.1002/slct.202103908</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Mishra</surname><given-names>M.</given-names></name>; <name><surname>Singh</surname><given-names>V.</given-names></name>; <name><surname>Tellis</surname><given-names>M. B.</given-names></name>; <name><surname>Joshi</surname><given-names>R. S.</given-names></name>; <name><surname>Pandey</surname><given-names>K. C.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name><article-title>Cyclic peptide engineered from phytocystatin inhibitory hairpin loop
as an effective modulator of falcipains and potent antimalarial</article-title>. <source>J. Biomol. Struct. Dyn.</source><year>2022</year>, <volume>40</volume>, <fpage>3642</fpage>–<lpage>3654</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2020.1848629</pub-id>.<pub-id pub-id-type="pmid">33292080</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Musyoka</surname><given-names>T. M.</given-names></name>; <name><surname>Njuguna</surname><given-names>J. N.</given-names></name>; <name><surname>Tastan Bishop</surname><given-names>Ö.</given-names></name><article-title>Comparing sequence and structure
of falcipains and human homologs at prodomain and catalytic active
site for malarial peptide based inhibitor design</article-title>. <source>Malar. J.</source><year>2019</year>, <volume>18</volume>, <fpage>1</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">30602373</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Lhouvum</surname><given-names>K.</given-names></name>; <name><surname>Bhuyar</surname><given-names>K. S.</given-names></name>; <name><surname>Trivedi</surname><given-names>V.</given-names></name><article-title>Molecular
modeling and correlation
of PFI1625c-peptide models of bioactive peptides with antimalarial
properties</article-title>. <source>Med. Chem. Res.</source><year>2015</year>, <volume>24</volume>, <fpage>1527</fpage>–<lpage>1533</lpage>. <pub-id pub-id-type="doi">10.1007/s00044-014-1232-5</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><person-group person-group-type="allauthors"><name><surname>Mehta</surname><given-names>D.</given-names></name>; <name><surname>Anand</surname><given-names>P.</given-names></name>; <name><surname>Kumar</surname><given-names>V.</given-names></name>; <name><surname>Joshi</surname><given-names>A.</given-names></name>; <name><surname>Mathur</surname><given-names>D.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Tuknait</surname><given-names>A.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Gautam</surname><given-names>S. K.</given-names></name>; <name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Varshney</surname><given-names>G. C.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name></person-group><article-title>ParaPep: a web resource for experimentally validated
antiparasitic peptide sequences and their structures</article-title>. <source>Database</source><year>2014</year>, <volume>2014</volume>, <pub-id pub-id-type="doi">10.1093/database/bau051</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Silva</surname><given-names>A. F.</given-names></name>; <name><surname>Torres</surname><given-names>M. D. T.</given-names></name>; <name><surname>Silva</surname><given-names>L.</given-names></name>; <name><surname>Alves</surname><given-names>F. L.</given-names></name>; <name><surname>Pinheiro</surname><given-names>A. A. D. S.</given-names></name>; <name><surname>Miranda</surname><given-names>A.</given-names></name>; <name><surname>Capurro</surname><given-names>M. L.</given-names></name>; <name><surname>Oliveira</surname><given-names>V. X.</given-names></name><article-title>New linear antiplasmodial
peptides related to angiotensin II</article-title>. <source>Malar. J.</source><year>2015</year>, <volume>14</volume>, <fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1186/s12936-015-0974-y</pub-id>.<pub-id pub-id-type="pmid">25557741</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Mahindra</surname><given-names>A.</given-names></name>; <name><surname>Gangwal</surname><given-names>R. P.</given-names></name>; <name><surname>Bansal</surname><given-names>S.</given-names></name>; <name><surname>Goldfarb</surname><given-names>N. E.</given-names></name>; <name><surname>Dunn</surname><given-names>B. M.</given-names></name>; <name><surname>Sangamwar</surname><given-names>A. T.</given-names></name>; <name><surname>Jain</surname><given-names>R.</given-names></name><article-title>Antiplasmodial activity of short
peptide-based compounds</article-title>. <source>RSC Adv.</source><year>2015</year>, <volume>5</volume>, <fpage>22674</fpage>–<lpage>22684</lpage>. <pub-id pub-id-type="doi">10.1039/C5RA00779H</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Choi</surname><given-names>S.-J.</given-names></name>; <name><surname>Parent</surname><given-names>R.</given-names></name>; <name><surname>Guillaume</surname><given-names>C.</given-names></name>; <name><surname>Deregnaucourt</surname><given-names>C.</given-names></name>; <name><surname>Delarbre</surname><given-names>C.</given-names></name>; <name><surname>Ojcius</surname><given-names>D. M.</given-names></name>; <name><surname>Montagne</surname><given-names>J.-J.</given-names></name>; <name><surname>Célérier</surname><given-names>M.-L.</given-names></name>; <name><surname>Phelipot</surname><given-names>A.</given-names></name>; <name><surname>Amiche</surname><given-names>M.</given-names></name>; <name><surname>Molgo</surname><given-names>J.</given-names></name>; <name><surname>Camadro</surname><given-names>J. M.</given-names></name>; <name><surname>Guette</surname><given-names>C.</given-names></name><article-title>Isolation and characterization of Psalmopeotoxin I
and II: two novel antimalarial peptides from the venom of the tarantula
Psalmopoeus cambridgei</article-title>. <source>FEBS Lett.</source><year>2004</year>, <volume>572</volume>, <fpage>109</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2004.07.019</pub-id>.<pub-id pub-id-type="pmid">15304333</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>Kokoza</surname><given-names>V.</given-names></name>; <name><surname>Ahmed</surname><given-names>A.</given-names></name>; <name><surname>Woon Shin</surname><given-names>S.</given-names></name>; <name><surname>Okafor</surname><given-names>N.</given-names></name>; <name><surname>Zou</surname><given-names>Z.</given-names></name>; <name><surname>Raikhel</surname><given-names>A. S.</given-names></name><article-title>Blocking of Plasmodium
transmission by cooperative
action of Cecropin A and Defensin A in transgenic Aedes aegypti mosquitoes</article-title>. <source>Proc. Natl. Acad. Sci.</source><year>2010</year>, <volume>107</volume>, <fpage>8111</fpage>–<lpage>8116</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1003056107</pub-id>.<pub-id pub-id-type="pmid">20385844</pub-id></mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Krugliak</surname><given-names>M.</given-names></name>; <name><surname>Feder</surname><given-names>R.</given-names></name>; <name><surname>Zolotarev</surname><given-names>V. Y.</given-names></name>; <name><surname>Gaidukov</surname><given-names>L.</given-names></name>; <name><surname>Dagan</surname><given-names>A.</given-names></name>; <name><surname>Ginsburg</surname><given-names>H.</given-names></name>; <name><surname>Mor</surname><given-names>A.</given-names></name><article-title>Antimalarial activities of dermaseptin
S4 derivatives</article-title>. <source>Antimicrob. Agents Chemother.</source><year>2000</year>, <volume>44</volume>, <fpage>2442</fpage>–<lpage>2451</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.44.9.2442-2451.2000</pub-id>.<pub-id pub-id-type="pmid">10952593</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Xiao</surname><given-names>X.</given-names></name>; <name><surname>Shao</surname><given-names>Y.-T.</given-names></name>; <name><surname>Cheng</surname><given-names>X.</given-names></name>; <name><surname>Stamatovic</surname><given-names>B.</given-names></name><article-title>iAMP-CA2L:
a new CNN-BiLSTM-SVM classifier based on cellular automata image for
identifying antimicrobial peptides and their functional types</article-title>. <source>Brief. Bioinf.</source><year>2021</year>, <volume>22</volume>, <elocation-id>bbab209</elocation-id><pub-id pub-id-type="doi">10.1093/bib/bbab209</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Agrawal</surname><given-names>P.</given-names></name>; <name><surname>Bhagat</surname><given-names>D.</given-names></name>; <name><surname>Mahalwal</surname><given-names>M.</given-names></name>; <name><surname>Sharma</surname><given-names>N.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name><article-title>AntiCP
2.0: an updated model for predicting anticancer peptides</article-title>. <source>Brief. Bioinf.</source><year>2021</year>, <volume>22</volume>, <elocation-id>bbaa153</elocation-id><pub-id pub-id-type="doi">10.1093/bib/bbaa153</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="journal" id="cit36"><name><surname>Huang</surname><given-names>H.-L.</given-names></name>; <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Kao</surname><given-names>T.-F.</given-names></name>; <name><surname>Lee</surname><given-names>H.-C.</given-names></name>; <name><surname>Chang</surname><given-names>F.-L.</given-names></name>; <name><surname>Huang</surname><given-names>W.-L.</given-names></name>; <name><surname>Ho</surname><given-names>S.-J.</given-names></name>; <name><surname>Shu</surname><given-names>L.-S.</given-names></name>; <name><surname>Chen</surname><given-names>W.-L.</given-names></name>; <name><surname>Ho</surname><given-names>S.-Y.</given-names></name><article-title>Prediction
and analysis of protein solubility using a novel scoring
card method with dipeptide composition</article-title>. <source>BMC
Bioinf.</source><year>2012</year>, <volume>13</volume>, <fpage>1</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-13-S17-S3</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>Vasylenko</surname><given-names>T.</given-names></name>; <name><surname>Liou</surname><given-names>Y.-F.</given-names></name>; <name><surname>Chiou</surname><given-names>P.-C.</given-names></name>; <name><surname>Chu</surname><given-names>H.-W.</given-names></name>; <name><surname>Lai</surname><given-names>Y.-S.</given-names></name>; <name><surname>Chou</surname><given-names>Y.-L.</given-names></name>; <name><surname>Huang</surname><given-names>H.-L.</given-names></name>; <name><surname>Ho</surname><given-names>S.-Y.</given-names></name><article-title>SCMBYK: prediction
and characterization of bacterial tyrosine-kinases based on propensity
scores of dipeptides</article-title>. <source>BMC Bioinf.</source><year>2016</year>, <volume>17</volume>, <fpage>203</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1186/s12859-016-1371-4</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name>; <name><surname>Lee</surname><given-names>H.-C.</given-names></name>; <name><surname>Chaijaruwanich</surname><given-names>J.</given-names></name>; <name><surname>Huang</surname><given-names>H.-L.</given-names></name>; <name><surname>Ho</surname><given-names>S.-Y.</given-names></name><article-title>SCMCRYS: predicting protein crystallization
using an ensemble scoring card method with estimating propensity scores
of P-collocated amino acid pairs</article-title>. <source>PLoS One</source><year>2013</year>, <volume>8</volume>, <elocation-id>e72368</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0072368</pub-id>.<pub-id pub-id-type="pmid">24019868</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="journal" id="cit39"><name><surname>Liou</surname><given-names>Y.-F.</given-names></name>; <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Srinivasulu</surname><given-names>Y. S.</given-names></name>; <name><surname>Vasylenko</surname><given-names>T.</given-names></name>; <name><surname>Lai</surname><given-names>S.-C.</given-names></name>; <name><surname>Lee</surname><given-names>H.-C.</given-names></name>; <name><surname>Chen</surname><given-names>Y.-H.</given-names></name>; <name><surname>Huang</surname><given-names>H.-L.</given-names></name>; <name><surname>Ho</surname><given-names>S.-Y.</given-names></name><article-title>SCMHBP: prediction
and analysis of heme binding proteins using propensity
scores of dipeptides</article-title>. <source>BMC Bioinf.</source><year>2014</year>, <volume>15</volume>, <fpage>1</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-15-S16-S4</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="journal" id="cit40"><name><surname>Vasylenko</surname><given-names>T.</given-names></name>; <name><surname>Liou</surname><given-names>Y.-F.</given-names></name>; <name><surname>Chen</surname><given-names>H.-A.</given-names></name>; <name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Huang</surname><given-names>H.-L.</given-names></name>; <name><surname>Ho</surname><given-names>S.-Y.</given-names></name><article-title>SCMPSP: Prediction and characterization
of photosynthetic proteins based on a scoring card method</article-title>. <source>BMC Bioinf.</source><year>2015</year>, <fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-16-S1-S8</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Chiangjong</surname><given-names>W.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Moni</surname><given-names>M. A.</given-names></name>; <name><surname>Lio’</surname><given-names>P.</given-names></name>; <name><surname>Manavalan</surname><given-names>B.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>SCMTHP: A New Approach for Identifying
and Characterizing of Tumor-Homing Peptides Using Estimated Propensity
Scores of Amino Acids</article-title>. <source>Pharmaceutics</source><year>2022</year>, <volume>14</volume>, <fpage>122</fpage><pub-id pub-id-type="doi">10.3390/pharmaceutics14010122</pub-id>.<pub-id pub-id-type="pmid">35057016</pub-id></mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Chiangjong</surname><given-names>W.</given-names></name>; <name><surname>Lee</surname><given-names>V. S.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Hasan</surname><given-names>M. M.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>Improved prediction and characterization
of anticancer activities of peptides using a novel flexible scoring
card method</article-title>. <source>Sci. Rep.</source><year>2021</year>, <volume>11</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics14010122</pub-id>.<pub-id pub-id-type="pmid">33414495</pub-id></mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="journal" id="cit43"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Chotpatiwetchkul</surname><given-names>W.</given-names></name>; <name><surname>Lee</surname><given-names>V. S.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>A novel sequence-based predictor for identifying and
characterizing thermophilic proteins using estimated propensity scores
of dipeptides</article-title>. <source>Sci. Rep.</source><year>2021</year>, <volume>11</volume>, <fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-03293-w</pub-id>.<pub-id pub-id-type="pmid">33414495</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Kawashima</surname><given-names>S.</given-names></name>; <name><surname>Pokarowski</surname><given-names>P.</given-names></name>; <name><surname>Pokarowska</surname><given-names>M.</given-names></name>; <name><surname>Kolinski</surname><given-names>A.</given-names></name>; <name><surname>Katayama</surname><given-names>T.</given-names></name>; <name><surname>Kanehisa</surname><given-names>M.</given-names></name><article-title>AAindex: amino acid
index database, progress report
2008</article-title>. <source>Nucleic Acids Res.</source><year>2007</year>, <volume>36</volume>, <fpage>D202</fpage>–<lpage>D205</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm998</pub-id>.<pub-id pub-id-type="pmid">17998252</pub-id></mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="journal" id="cit45"><name><surname>Chen</surname><given-names>Z.</given-names></name>; <name><surname>Zhao</surname><given-names>P.</given-names></name>; <name><surname>Li</surname><given-names>F.</given-names></name>; <name><surname>Leier</surname><given-names>A.</given-names></name>; <name><surname>Marquez-Lago</surname><given-names>T. T.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Webb</surname><given-names>G. I.</given-names></name>; <name><surname>Smith</surname><given-names>A. I.</given-names></name>; <name><surname>Daly</surname><given-names>R. J.</given-names></name>; <name><surname>Chou</surname><given-names>K.-C.</given-names></name>; <name><surname>Song</surname><given-names>J.</given-names></name><article-title>iFeature: a python package and web
server for features extraction and selection from protein and peptide
sequences</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>2499</fpage>–<lpage>2502</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bty140</pub-id>.<pub-id pub-id-type="pmid">29528364</pub-id></mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="journal" id="cit46"><name><surname>Pedregosa</surname><given-names>F.</given-names></name>; <name><surname>Varoquaux</surname><given-names>G.</given-names></name>; <name><surname>Gramfort</surname><given-names>A.</given-names></name>; <name><surname>Michel</surname><given-names>V.</given-names></name>; <name><surname>Thirion</surname><given-names>B.</given-names></name>; <name><surname>Grisel</surname><given-names>O.</given-names></name>; <name><surname>Blondel</surname><given-names>M.</given-names></name>; <name><surname>Prettenhofer</surname><given-names>P.</given-names></name>; <name><surname>Weiss</surname><given-names>R.</given-names></name>; <name><surname>Dubourg</surname><given-names>V.</given-names></name><article-title>Scikit-learn: Machine learning in
Python</article-title>. <source>J. Mach. Learn. Res.</source><year>2011</year>, <volume>12</volume>, <fpage>2825</fpage>–<lpage>2830</lpage>.</mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Chiangjong</surname><given-names>W.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Hasan</surname><given-names>M. M.</given-names></name>; <name><surname>Manavalan</surname><given-names>B.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>StackIL6:
a stacking ensemble model for improving the
prediction of IL-6 inducing peptides</article-title>. <source>Brief.
Bioinf.</source><year>2021</year>, <volume>22</volume>, <elocation-id>bbab172</elocation-id><pub-id pub-id-type="doi">10.1093/bib/bbab172</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Hasan</surname><given-names>M. M.</given-names></name>; <name><surname>Manavalan</surname><given-names>B.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>BERT4Bitter:
a bidirectional encoder representations
from transformers (BERT)-based model for improving the prediction
of bitter peptides</article-title>. <source>Bioinformatics</source><year>2021</year>, <volume>37</volume>, <fpage>2556</fpage>–<lpage>2562</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btab133</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="journal" id="cit49"><name><surname>Azadpour</surname><given-names>M.</given-names></name>; <name><surname>McKay</surname><given-names>C. M.</given-names></name>; <name><surname>Smith</surname><given-names>R. L.</given-names></name><article-title>Estimating
confidence intervals for
information transfer analysis of confusion matrices</article-title>. <source>J. Acoust. Soc. Am.</source><year>2014</year>, <volume>135</volume>, <fpage>EL140</fpage>–<lpage>EL146</lpage>. <pub-id pub-id-type="doi">10.1121/1.4865840</pub-id>.<pub-id pub-id-type="pmid">24606307</pub-id></mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="journal" id="cit50"><name><surname>Lv</surname><given-names>H.</given-names></name>; <name><surname>Dao</surname><given-names>F.-Y.</given-names></name>; <name><surname>Guan</surname><given-names>Z.-X.</given-names></name>; <name><surname>Yang</surname><given-names>H.</given-names></name>; <name><surname>Li</surname><given-names>Y.-W.</given-names></name>; <name><surname>Lin</surname><given-names>H.</given-names></name><article-title>Deep-Kcr: accurate
detection of lysine crotonylation sites using
deep learning method</article-title>. <source>Brief. Bioinf.</source><year>2021</year>, <volume>22</volume>, <elocation-id>bbaa255</elocation-id><pub-id pub-id-type="doi">10.1093/bib/bbaa255</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Lv</surname><given-names>H.</given-names></name>; <name><surname>Dao</surname><given-names>F.-Y.</given-names></name>; <name><surname>Zulfiqar</surname><given-names>H.</given-names></name>; <name><surname>Su</surname><given-names>W.</given-names></name>; <name><surname>Ding</surname><given-names>H.</given-names></name>; <name><surname>Liu</surname><given-names>L.</given-names></name>; <name><surname>Lin</surname><given-names>H.</given-names></name><article-title>A sequence-based deep learning approach to predict
CTCF-mediated chromatin loop</article-title>. <source>Brief. Bioinf.</source><year>2021</year>, <elocation-id>bbab031</elocation-id>.</mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="journal" id="cit52"><name><surname>Wang</surname><given-names>D.</given-names></name>; <name><surname>Zhang</surname><given-names>Z.</given-names></name>; <name><surname>Jiang</surname><given-names>Y.</given-names></name>; <name><surname>Mao</surname><given-names>Z.</given-names></name>; <name><surname>Wang</surname><given-names>D.</given-names></name>; <name><surname>Lin</surname><given-names>H.</given-names></name>; <name><surname>Xu</surname><given-names>D.</given-names></name><article-title>DM3Loc: multi-label mRNA subcellular localization prediction
and analysis based on multi-head self-attention mechanism</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>e46</fpage>–<lpage>e46</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab016</pub-id>.<pub-id pub-id-type="pmid">33503258</pub-id></mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Dao</surname><given-names>F.-Y.</given-names></name>; <name><surname>Lv</surname><given-names>H.</given-names></name>; <name><surname>Zulfiqar</surname><given-names>H.</given-names></name>; <name><surname>Yang</surname><given-names>H.</given-names></name>; <name><surname>Su</surname><given-names>W.</given-names></name>; <name><surname>Gao</surname><given-names>H.</given-names></name>; <name><surname>Ding</surname><given-names>H.</given-names></name>; <name><surname>Lin</surname><given-names>H.</given-names></name><article-title>A computational platform to identify
origins of replication sites in eukaryotes</article-title>. <source>Brief. Bioinf.</source><year>2021</year>, <volume>22</volume>, <fpage>1940</fpage>–<lpage>1950</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bbaa017</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="journal" id="cit54"><name><surname>Dao</surname><given-names>F.-Y.</given-names></name>; <name><surname>Lv</surname><given-names>H.</given-names></name>; <name><surname>Zhang</surname><given-names>D.</given-names></name>; <name><surname>Zhang</surname><given-names>Z.-M.</given-names></name>; <name><surname>Liu</surname><given-names>L.</given-names></name>; <name><surname>Lin</surname><given-names>H.</given-names></name><article-title>DeepYY1: a
deep learning approach to identify YY1-mediated chromatin loops</article-title>. <source>Brief. Bioinf.</source><year>2021</year>, <volume>22</volume>, <elocation-id>bbaa356</elocation-id><pub-id pub-id-type="doi">10.1093/bib/bbaa356</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="journal" id="cit55"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Kanthawong</surname><given-names>S.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Hasan</surname><given-names>M. M.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>iAMY-SCM:
Improved prediction and analysis of amyloid proteins using a scoring
card method with propensity scores of dipeptides</article-title>. <source>Genomics</source><year>2020</year>, <fpage>2813</fpage><pub-id pub-id-type="doi">10.1016/j.ygeno.2020.03.019</pub-id>.<pub-id pub-id-type="pmid">32234434</pub-id></mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="journal" id="cit56"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Kanthawong</surname><given-names>S.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Hasan</surname><given-names>M. M.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>iDPPIV-SCM:
A sequence-based predictor for identifying and analyzing dipeptidyl
peptidase IV (DPP-IV) inhibitory peptides using a scoring card method</article-title>. <source>J. Proteome Res.</source><year>2020</year>, <volume>19</volume>, <fpage>4125</fpage>–<lpage>4136</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.0c00590</pub-id>.<pub-id pub-id-type="pmid">32897718</pub-id></mixed-citation>
    </ref>
    <ref id="ref57">
      <mixed-citation publication-type="journal" id="cit57"><name><surname>Chaianantakul</surname><given-names>N.</given-names></name>; <name><surname>Sungkapong</surname><given-names>T.</given-names></name>; <name><surname>Supatip</surname><given-names>J.</given-names></name>; <name><surname>Kingsang</surname><given-names>P.</given-names></name>; <name><surname>Kamlaithong</surname><given-names>S.</given-names></name>; <name><surname>Suwanakitti</surname><given-names>N.</given-names></name><article-title>Antimalarial effect of cell penetrating peptides derived
from the junctional region of Plasmodium falciparum dihydrofolate
reductase-thymidylate synthase</article-title>. <source>Peptides</source><year>2020</year>, <volume>131</volume>, <elocation-id>170372</elocation-id><pub-id pub-id-type="doi">10.1016/j.peptides.2020.170372</pub-id>.<pub-id pub-id-type="pmid">32673701</pub-id></mixed-citation>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="journal" id="cit58"><name><surname>Bianchin</surname><given-names>A.</given-names></name>; <name><surname>Bell</surname><given-names>A.</given-names></name>; <name><surname>Chubb</surname><given-names>A. J.</given-names></name>; <name><surname>Doolan</surname><given-names>N.</given-names></name>; <name><surname>Leneghan</surname><given-names>D.</given-names></name>; <name><surname>Stavropoulos</surname><given-names>I.</given-names></name>; <name><surname>Shields</surname><given-names>D. C.</given-names></name>; <name><surname>Mooney</surname><given-names>C.</given-names></name><article-title>Design and evaluation
of antimalarial peptides derived from prediction of short linear motifs
in proteins related to erythrocyte invasion</article-title>. <source>PLoS One</source><year>2015</year>, <volume>10</volume>, <elocation-id>e0127383</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0127383</pub-id>.<pub-id pub-id-type="pmid">26039561</pub-id></mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="journal" id="cit59"><name><surname>Sinha</surname><given-names>S.</given-names></name>; <name><surname>Singh</surname><given-names>A.</given-names></name>; <name><surname>Medhi</surname><given-names>B.</given-names></name>; <name><surname>Sehgal</surname><given-names>R.</given-names></name><article-title>Systematic review:
insight into antimalarial peptide</article-title>. <source>Int. J. Pept.
Res. Ther.</source><year>2016</year>, <volume>22</volume>, <fpage>325</fpage>–<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1007/s10989-016-9512-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="journal" id="cit60"><name><surname>Leussa</surname><given-names>A. N.-N.</given-names></name>; <name><surname>Rautenbach</surname><given-names>M.</given-names></name><article-title>Antiplasmodial
Cyclodecapeptides from Tyrothricin Share
a Target with Chloroquine</article-title>. <source>Antibiotics</source><year>2022</year>, <volume>11</volume>, <fpage>801</fpage><pub-id pub-id-type="doi">10.3390/antibiotics11060801</pub-id>.<pub-id pub-id-type="pmid">35740207</pub-id></mixed-citation>
    </ref>
    <ref id="ref61">
      <mixed-citation publication-type="journal" id="cit61"><name><surname>Thongtan</surname><given-names>J.</given-names></name>; <name><surname>Saenboonrueng</surname><given-names>J.</given-names></name>; <name><surname>Rachtawee</surname><given-names>P.</given-names></name>; <name><surname>Isaka</surname><given-names>M.</given-names></name><article-title>An antimalarial tetrapeptide
from the entomopathogenic fungus Hirsutella sp. BCC 1528</article-title>. <source>J. Nat. Prod.</source><year>2006</year>, <volume>69</volume>, <fpage>713</fpage>–<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1021/np050549h</pub-id>.<pub-id pub-id-type="pmid">16643062</pub-id></mixed-citation>
    </ref>
    <ref id="ref62">
      <mixed-citation publication-type="journal" id="cit62"><name><surname>Ferreira</surname><given-names>L. H. R.</given-names></name>; <name><surname>Silva</surname><given-names>A. F.</given-names></name>; <name><surname>Torres</surname><given-names>M. D. T.</given-names></name>; <name><surname>Pedron</surname><given-names>C. N.</given-names></name>; <name><surname>Capurro</surname><given-names>M. L.</given-names></name>; <name><surname>Alves</surname><given-names>F. L.</given-names></name>; <name><surname>Miranda</surname><given-names>A.</given-names></name>; <name><surname>Oliveira</surname><given-names>V. X.</given-names></name><article-title>Effects of Amino
Acid deletion on the antiplasmodial activity of angiotensin II</article-title>. <source>Int. J. Pept. Res. Ther.</source><year>2014</year>, <volume>20</volume>, <fpage>553</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1007/s10989-014-9425-9</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref63">
      <mixed-citation publication-type="journal" id="cit63"><name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Brady</surname><given-names>A.</given-names></name>; <name><surname>Young</surname><given-names>A.</given-names></name>; <name><surname>Rasimick</surname><given-names>B.</given-names></name>; <name><surname>Chen</surname><given-names>K.</given-names></name>; <name><surname>Zhou</surname><given-names>C.</given-names></name>; <name><surname>Kallenbach</surname><given-names>N. R.</given-names></name><article-title>Length effects in antimicrobial peptides
of the (RW) n series</article-title>. <source>Antimicrob. Agents Chemother.</source><year>2007</year>, <volume>51</volume>, <fpage>597</fpage>–<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00828-06</pub-id>.<pub-id pub-id-type="pmid">17145799</pub-id></mixed-citation>
    </ref>
    <ref id="ref64">
      <mixed-citation publication-type="journal" id="cit64"><name><surname>Tzakos</surname><given-names>A. G.</given-names></name>; <name><surname>Bonvin</surname><given-names>A. M.</given-names></name>; <name><surname>Troganis</surname><given-names>A.</given-names></name>; <name><surname>Cordopatis</surname><given-names>P.</given-names></name>; <name><surname>Amzel</surname><given-names>M. L.</given-names></name>; <name><surname>Gerothanassis</surname><given-names>I. P.</given-names></name>; <name><surname>Van Nuland</surname><given-names>N. A.</given-names></name><article-title>On the
molecular basis of the recognition of angiotensin II (AII) NMR structure
of AII in solution compared with the X-ray structure of AII bound
to the mAb Fab131</article-title>. <source>Eur. J. Biochem.</source><year>2003</year>, <volume>270</volume>, <fpage>849</fpage>–<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1046/j.1432-1033.2003.03441.x</pub-id>.<pub-id pub-id-type="pmid">12603318</pub-id></mixed-citation>
    </ref>
    <ref id="ref65">
      <mixed-citation publication-type="book" id="cit65"><person-group person-group-type="allauthors"><name><surname>de Freitas</surname><given-names>D. M.</given-names></name>; <name><surname>Junior</surname><given-names>V. X. O.</given-names></name></person-group><article-title>Antiplasmodial Activity of Angiotensin II Analogs</article-title>. <source>Proceedings of the 24 th American Peptide Symposium</source>; <publisher-name>American Peptide Society</publisher-name>, <year>2015</year>.</mixed-citation>
    </ref>
    <ref id="ref66">
      <mixed-citation publication-type="journal" id="cit66"><name><surname>Dennison</surname><given-names>S.</given-names></name>; <name><surname>Harris</surname><given-names>F.</given-names></name>; <name><surname>Phoenix</surname><given-names>D.</given-names></name><article-title>A study on
the importance of phenylalanine
for aurein functionality</article-title>. <source>Protein Pept. Lett.</source><year>2009</year>, <volume>16</volume>, <fpage>1455</fpage>–<lpage>1458</lpage>. <pub-id pub-id-type="doi">10.2174/092986609789839340</pub-id>.<pub-id pub-id-type="pmid">20001908</pub-id></mixed-citation>
    </ref>
    <ref id="ref67">
      <mixed-citation publication-type="journal" id="cit67"><name><surname>Pérez-Picaso</surname><given-names>L.</given-names></name>; <name><surname>Velasco-Bejarano</surname><given-names>B.</given-names></name>; <name><surname>Aguilar-Guadarrama</surname><given-names>A.
B.</given-names></name>; <name><surname>Argotte-Ramos</surname><given-names>R.</given-names></name>; <name><surname>Rios</surname><given-names>M. Y.</given-names></name><article-title>Antimalarial activity of ultra-short peptides</article-title>. <source>Molecules</source><year>2009</year>, <volume>14</volume>, <fpage>5103</fpage>–<lpage>5114</lpage>. <pub-id pub-id-type="doi">10.3390/molecules14125103</pub-id>.<pub-id pub-id-type="pmid">20032878</pub-id></mixed-citation>
    </ref>
    <ref id="ref68">
      <mixed-citation publication-type="journal" id="cit68"><name><surname>Mason</surname><given-names>A. J.</given-names></name>; <name><surname>Moussaoui</surname><given-names>W.</given-names></name>; <name><surname>Abdelrahman</surname><given-names>T.</given-names></name>; <name><surname>Boukhari</surname><given-names>A.</given-names></name>; <name><surname>Bertani</surname><given-names>P.</given-names></name>; <name><surname>Marquette</surname><given-names>A.</given-names></name>; <name><surname>Shooshtarizaheh</surname><given-names>P.</given-names></name>; <name><surname>Moulay</surname><given-names>G.</given-names></name>; <name><surname>Boehm</surname><given-names>N.</given-names></name>; <name><surname>Guerold</surname><given-names>B.</given-names></name>; <name><surname>Sawers</surname><given-names>R. J. H.</given-names></name>; <name><surname>Kichler</surname><given-names>A.</given-names></name>; <name><surname>Metz-Boutigue</surname><given-names>M. H.</given-names></name>; <name><surname>Candolfi</surname><given-names>E.</given-names></name>; <name><surname>Právost</surname><given-names>G.</given-names></name>; <name><surname>Bechinger</surname><given-names>B.</given-names></name><article-title>Structural
determinants of antimicrobial and antiplasmodial activity and selectivity
in histidine-rich amphipathic cationic peptides</article-title>. <source>J. Biol. Chem.</source><year>2009</year>, <volume>284</volume>, <fpage>119</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M806201200</pub-id>.<pub-id pub-id-type="pmid">18984589</pub-id></mixed-citation>
    </ref>
    <ref id="ref69">
      <mixed-citation publication-type="journal" id="cit69"><name><surname>Takano</surname><given-names>K.</given-names></name>; <name><surname>Yutani</surname><given-names>K.</given-names></name><article-title>A new scale for side-chain
contribution to protein
stability based on the empirical stability analysis of mutant proteins</article-title>. <source>Protein Eng., Des. Sel.</source><year>2001</year>, <volume>14</volume>, <fpage>525</fpage>–<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1093/protein/14.8.525</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref70">
      <mixed-citation publication-type="journal" id="cit70"><name><surname>Black</surname><given-names>S. D.</given-names></name>; <name><surname>Mould</surname><given-names>D. R.</given-names></name><article-title>Development of hydrophobicity
parameters to analyze
proteins which bear post-or cotranslational modifications</article-title>. <source>Anal. Biochem.</source><year>1991</year>, <volume>193</volume>, <fpage>72</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/0003-2697(91)90045-U</pub-id>.<pub-id pub-id-type="pmid">2042744</pub-id></mixed-citation>
    </ref>
    <ref id="ref71">
      <mixed-citation publication-type="journal" id="cit71"><name><surname>Silva</surname><given-names>A. F.</given-names></name>; <name><surname>Bastos</surname><given-names>E. L.</given-names></name>; <name><surname>Torres</surname><given-names>M. D. T.</given-names></name>; <name><surname>Costa-da-Silva</surname><given-names>A. L.</given-names></name>; <name><surname>Ioshino</surname><given-names>R. S.</given-names></name>; <name><surname>Capurro</surname><given-names>M. L.</given-names></name>; <name><surname>Alves</surname><given-names>F. L.</given-names></name>; <name><surname>Miranda</surname><given-names>A.</given-names></name>; <name><surname>De Freitas Fischer Vieira</surname><given-names>R.</given-names></name>; <name><surname>Oliveira</surname><given-names>V. X.</given-names><suffix>Jr.</suffix></name><article-title>Antiplasmodial activity study of
angiotensin II via Ala scan analogs</article-title>. <source>J. Pept.
Sci.</source><year>2014</year>, <volume>20</volume>, <fpage>640</fpage>–<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1002/psc.2641</pub-id>.<pub-id pub-id-type="pmid">24817179</pub-id></mixed-citation>
    </ref>
    <ref id="ref72">
      <mixed-citation publication-type="journal" id="cit72"><name><surname>Osorio</surname><given-names>D.</given-names></name>; <name><surname>Rondón-Villarreal</surname><given-names>P.</given-names></name>; <name><surname>Torres</surname><given-names>R.</given-names></name><article-title>Peptides: a package
for data mining of antimicrobial peptides</article-title>. <source>Small</source><year>2015</year>, <volume>12</volume>, <fpage>44</fpage>–<lpage>444</lpage>.</mixed-citation>
    </ref>
    <ref id="ref73">
      <mixed-citation publication-type="journal" id="cit73"><name><surname>Cid</surname><given-names>H.</given-names></name>; <name><surname>Bunster</surname><given-names>M.</given-names></name>; <name><surname>Canales</surname><given-names>M.</given-names></name>; <name><surname>Gazitúa</surname><given-names>F.</given-names></name><article-title>Hydrophobicity
and structural classes in proteins</article-title>. <source>Protein
Eng., Des. Sel.</source><year>1992</year>, <volume>5</volume>, <fpage>373</fpage>–<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1093/protein/5.5.373</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref74">
      <mixed-citation publication-type="journal" id="cit74"><name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Guarnieri</surname><given-names>M. T.</given-names></name>; <name><surname>Vasil</surname><given-names>A. I.</given-names></name>; <name><surname>Vasil</surname><given-names>M. L.</given-names></name>; <name><surname>Mant</surname><given-names>C. T.</given-names></name>; <name><surname>Hodges</surname><given-names>R. S.</given-names></name><article-title>Role of
peptide hydrophobicity in the mechanism of
action of α-helical antimicrobial peptides</article-title>. <source>Antimicrob. Agents Chemother.</source><year>2007</year>, <volume>51</volume>, <fpage>1398</fpage>–<lpage>1406</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00925-06</pub-id>.<pub-id pub-id-type="pmid">17158938</pub-id></mixed-citation>
    </ref>
    <ref id="ref75">
      <mixed-citation publication-type="journal" id="cit75"><name><surname>Pane</surname><given-names>K.</given-names></name>; <name><surname>Durante</surname><given-names>L.</given-names></name>; <name><surname>Crescenzi</surname><given-names>O.</given-names></name>; <name><surname>Cafaro</surname><given-names>V.</given-names></name>; <name><surname>Pizzo</surname><given-names>E.</given-names></name>; <name><surname>Varcamonti</surname><given-names>M.</given-names></name>; <name><surname>Zanfardino</surname><given-names>A.</given-names></name>; <name><surname>Izzo</surname><given-names>V.</given-names></name>; <name><surname>Di Donato</surname><given-names>A.</given-names></name>; <name><surname>Notomista</surname><given-names>E.</given-names></name><article-title>Antimicrobial potency of cationic antimicrobial peptides
can be predicted from their amino acid composition: Application to
the detection of “cryptic” antimicrobial peptides</article-title>. <source>J. Theor. Biol.</source><year>2017</year>, <volume>419</volume>, <fpage>254</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtbi.2017.02.012</pub-id>.<pub-id pub-id-type="pmid">28216428</pub-id></mixed-citation>
    </ref>
    <ref id="ref76">
      <mixed-citation publication-type="journal" id="cit76"><name><surname>Fjell</surname><given-names>C. D.</given-names></name>; <name><surname>Hiss</surname><given-names>J. A.</given-names></name>; <name><surname>Hancock</surname><given-names>R. E. W.</given-names></name>; <name><surname>Schneider</surname><given-names>G.</given-names></name><article-title>Designing
antimicrobial peptides: form follows function</article-title>. <source>Nat. Rev. Drug. Discov.</source><year>2012</year>, <volume>11</volume>, <fpage>37</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1038/nrd3591</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref77">
      <mixed-citation publication-type="journal" id="cit77"><name><surname>Kawashima</surname><given-names>S.</given-names></name>; <name><surname>Kanehisa</surname><given-names>M.</given-names></name><article-title>AAindex: amino acid
index database</article-title>. <source>Nucleic Acids Res.</source><year>2000</year>, <volume>28</volume>, <fpage>374</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1093/nar/28.1.374</pub-id>.<pub-id pub-id-type="pmid">10592278</pub-id></mixed-citation>
    </ref>
    <ref id="ref78">
      <mixed-citation publication-type="journal" id="cit78"><name><surname>Biou</surname><given-names>V.</given-names></name>; <name><surname>Gibrat</surname><given-names>J. F.</given-names></name>; <name><surname>Levin</surname><given-names>J. M.</given-names></name>; <name><surname>Robson</surname><given-names>B.</given-names></name>; <name><surname>Garnier</surname><given-names>J.</given-names></name><article-title>Secondary
structure prediction: combination of three different methods</article-title>. <source>Protein Eng., Des. Sel.</source><year>1988</year>, <volume>2</volume>, <fpage>185</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1093/protein/2.3.185</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref79">
      <mixed-citation publication-type="journal" id="cit79"><name><surname>Lehrer</surname><given-names>R. I.</given-names></name>; <name><surname>Barton</surname><given-names>A.</given-names></name>; <name><surname>Daher</surname><given-names>K. A.</given-names></name>; <name><surname>Harwig</surname><given-names>S. S.</given-names></name>; <name><surname>Ganz</surname><given-names>T.</given-names></name>; <name><surname>Selsted</surname><given-names>M. E.</given-names></name><article-title>Interaction of human
defensins with Escherichia coli.
Mechanism of bactericidal activity</article-title>. <source>J. Clin.
Invest.</source><year>1989</year>, <volume>84</volume>, <fpage>553</fpage>–<lpage>561</lpage>. <pub-id pub-id-type="doi">10.1172/JCI114198</pub-id>.<pub-id pub-id-type="pmid">2668334</pub-id></mixed-citation>
    </ref>
    <ref id="ref80">
      <mixed-citation publication-type="journal" id="cit80"><name><surname>Wimley</surname><given-names>W. C.</given-names></name>; <name><surname>Selsted</surname><given-names>M. E.</given-names></name>; <name><surname>White</surname><given-names>S. H.</given-names></name><article-title>Interactions
between human defensins
and lipid bilayers: evidence for formation of multimeric pores</article-title>. <source>Protein Sci.</source><year>1994</year>, <volume>3</volume>, <fpage>1362</fpage>–<lpage>1373</lpage>. <pub-id pub-id-type="doi">10.1002/pro.5560030902</pub-id>.<pub-id pub-id-type="pmid">7833799</pub-id></mixed-citation>
    </ref>
    <ref id="ref81">
      <mixed-citation publication-type="journal" id="cit81"><name><surname>Piriou</surname><given-names>F.</given-names></name>; <name><surname>Lintner</surname><given-names>K.</given-names></name>; <name><surname>Fermandjian</surname><given-names>S.</given-names></name>; <name><surname>Fromageot</surname><given-names>P.</given-names></name>; <name><surname>Khosla</surname><given-names>M. C.</given-names></name>; <name><surname>Smeby</surname><given-names>R. R.</given-names></name>; <name><surname>Bumpus</surname><given-names>F. M.</given-names></name><article-title>Amino acid
side
chain conformation in angiotensin II and analogs: correlated results
of circular dichroism and 1H nuclear magnetic resonance</article-title>. <source>Proc. Natl. Acad. Sci.</source><year>1980</year>, <volume>77</volume>, <fpage>82</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.77.1.82</pub-id>.<pub-id pub-id-type="pmid">6928653</pub-id></mixed-citation>
    </ref>
    <ref id="ref82">
      <mixed-citation publication-type="journal" id="cit82"><name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Konings</surname><given-names>W. N.</given-names></name>; <name><surname>Driessen</surname><given-names>A. J.</given-names></name><article-title>Bacteriocins:
mechanism of membrane
insertion and pore formation</article-title>. <source>Antonie van Leeuwenhoek</source><year>1999</year>, <volume>76</volume>, <fpage>185</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1023/A:1002002718501</pub-id>.<pub-id pub-id-type="pmid">10532378</pub-id></mixed-citation>
    </ref>
    <ref id="ref83">
      <mixed-citation publication-type="journal" id="cit83"><name><surname>Richardson</surname><given-names>J. S.</given-names></name>; <name><surname>Richardson</surname><given-names>D. C.</given-names></name><article-title>Amino acid preferences for specific
locations at the
ends of α helices</article-title>. <source>Science</source><year>1988</year>, <volume>240</volume>, <fpage>1648</fpage>–<lpage>1652</lpage>. <pub-id pub-id-type="doi">10.1126/science.3381086</pub-id>.<pub-id pub-id-type="pmid">3381086</pub-id></mixed-citation>
    </ref>
    <ref id="ref84">
      <mixed-citation publication-type="journal" id="cit84"><name><surname>Kratochvil</surname><given-names>H. T.</given-names></name>; <name><surname>Newberry</surname><given-names>R. W.</given-names></name>; <name><surname>Mensa</surname><given-names>B.</given-names></name>; <name><surname>Mravic</surname><given-names>M.</given-names></name>; <name><surname>DeGrado</surname><given-names>W. F.</given-names></name><article-title>Spiers
Memorial Lecture: Analysis and de novo design of membrane-interactive
peptides</article-title>. <source>Faraday Discuss.</source><year>2021</year>, <volume>232</volume>, <fpage>9</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1039/D1FD00061F</pub-id>.<pub-id pub-id-type="pmid">34693965</pub-id></mixed-citation>
    </ref>
    <ref id="ref85">
      <mixed-citation publication-type="journal" id="cit85"><name><surname>Dathe</surname><given-names>M.</given-names></name>; <name><surname>Wieprecht</surname><given-names>T.</given-names></name>; <name><surname>Nikolenko</surname><given-names>H.</given-names></name>; <name><surname>Handel</surname><given-names>L.</given-names></name>; <name><surname>Maloy</surname><given-names>W. L.</given-names></name>; <name><surname>MacDonald</surname><given-names>D. L.</given-names></name>; <name><surname>Beyermann</surname><given-names>M.</given-names></name>; <name><surname>Bienert</surname><given-names>M.</given-names></name><article-title>Hydrophobicity, hydrophobic
moment and angle subtended by charged residues modulate antibacterial
and haemolytic activity of amphipathic helical peptides</article-title>. <source>FEBS Lett.</source><year>1997</year>, <volume>403</volume>, <fpage>208</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(97)00055-0</pub-id>.<pub-id pub-id-type="pmid">9042968</pub-id></mixed-citation>
    </ref>
    <ref id="ref86">
      <mixed-citation publication-type="journal" id="cit86"><name><surname>Maloy</surname><given-names>W. L.</given-names></name>; <name><surname>Kari</surname><given-names>U. P.</given-names></name><article-title>Structure–activity
studies on magainins and
other host defense peptides</article-title>. <source>Biopolymers</source><year>1995</year>, <volume>37</volume>, <fpage>105</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1002/bip.360370206</pub-id>.<pub-id pub-id-type="pmid">7893944</pub-id></mixed-citation>
    </ref>
    <ref id="ref87">
      <mixed-citation publication-type="journal" id="cit87"><name><surname>Zhong</surname><given-names>L.</given-names></name>; <name><surname>Putnam</surname><given-names>R. J.</given-names></name>; <name><surname>Johnson</surname><given-names>J. R.</given-names></name>; <name><surname>Rao</surname><given-names>A. G.</given-names></name><article-title>Design
and synthesis
of amphipathic antimicrobial peptides</article-title>. <source>Int.
J. Pept. Protein Res.</source><year>1995</year>, <volume>45</volume>, <fpage>337</fpage>–<lpage>347</lpage>.<pub-id pub-id-type="pmid">7601607</pub-id></mixed-citation>
    </ref>
    <ref id="ref88">
      <mixed-citation publication-type="journal" id="cit88"><name><surname>Sitaram</surname><given-names>N.</given-names></name>; <name><surname>Subbalakshmi</surname><given-names>C.</given-names></name>; <name><surname>Nagaraj</surname><given-names>R.</given-names></name><article-title>Structural and charge requirements
for antimicrobial and hemolytic activity in the peptide PKLLETFLSKWIG,
corresponding to the hydrophobic region of the antimicrobial protein
bovine seminalplasmin</article-title>. <source>Int. J. Pept. Protein
Res.</source><year>1995</year>, <volume>46</volume>, <fpage>166</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-3011.1995.tb01332.x</pub-id>.<pub-id pub-id-type="pmid">8567171</pub-id></mixed-citation>
    </ref>
    <ref id="ref89">
      <mixed-citation publication-type="journal" id="cit89"><name><surname>Bechinger</surname><given-names>B.</given-names></name><article-title>Rationalizing
the membrane interactions of cationic amphipathic antimicrobial peptides
by their molecular shape</article-title>. <source>Curr. Opin. Colloid
Interface Sci.</source><year>2009</year>, <volume>14</volume>, <fpage>349</fpage>–<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1016/j.cocis.2009.02.004</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref90">
      <mixed-citation publication-type="journal" id="cit90"><name><surname>Zasloff</surname><given-names>M.</given-names></name><article-title>Antimicrobial
peptides of multicellular organisms</article-title>. <source>Nature</source><year>2002</year>, <volume>415</volume>, <fpage>389</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1038/415389a</pub-id>.<pub-id pub-id-type="pmid">11807545</pub-id></mixed-citation>
    </ref>
    <ref id="ref91">
      <mixed-citation publication-type="journal" id="cit91"><name><surname>Hwang</surname><given-names>P. M.</given-names></name>; <name><surname>Vogel</surname><given-names>H. J.</given-names></name><article-title>Structure-function relationships of antimicrobial peptides</article-title>. <source>Biochem. Cell Biol.</source><year>1998</year>, <volume>76</volume>, <fpage>235</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1139/o98-026</pub-id>.<pub-id pub-id-type="pmid">9923692</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
